Hydrogen Peroxide: Apparently Good for you?

i've used it to treat cold sores (50/50 mix of water & 6% HP in a spray bottle) and it works wonderfully. i'm sure there are other benefits, havent tried it internally though - its quite hard to find food grade in Asia :\
 
New Article on the topic:

The Internet Journal of Plastic Surgery ISSN: 1528-8293

Hydrogen Peroxide: A review of a scientifically verifiable omnipresent ubiquitous essentiality of obligate, aerobic, carbon-based life forms


Randolph M. Howes MD, PhD Adjunct Assistant Professor of Plastic Surgery, The Johns Hopkins Hospital, Baltimore, Md., U.S.A., Espaldon Professor of Plastic and Reconstructive Surgery, University of Santo Tomas, Manila, Philippines. Adjunct Professor of Biological Sciences, Southeastern Louisiana University, Hammond, La.

Citation: R.M. Howes: Hydrogen Peroxide: A review of a scientifically verifiable omnipresent ubiquitous essentiality of obligate, aerobic, carbon-based life forms. The Internet Journal of Plastic Surgery. 2010 Volume 7 Number 1. DOI: 10.5580/2da
Abstract

Electronically modified oxygen derivatives (EMODs), such as superoxide anion and hydrogen peroxide, carry out highly sophisticated intra, inter and extra cellular signaling roles that are essential for normal biochemical functioning. Hydrogen peroxide is freely diffusible through cell membranes, can not be excluded from cells and is required for normal operation of many enzymes that maintain and promote health. Hydrogen peroxide can act as an enzymatic substrate or activate or inhibit redox sensitive enzymes. Large health related organizations, such as the American Cancer Society, continue to disregard and deride the potential beneficial involvement and contribution of EMODs, especially hydrogen peroxide, in the treatment of any disease condition, inclusive of cancer. Their position of disdain is not supported by an exhaustive review of the medical and scientific literature. Although hydrogen peroxide has on occasion been a proposed mutagen, oncogenic transformation primarily leads to an increase of cellular EMODs that renders these same cells selectively vulnerable to additional EMOD production via EMOD induced apoptosis or necrosis. Legitimate medical health agencies are obliged to embrace the widespread scientific supportive findings regarding prooxidant hydrogen peroxide existent in the literature and encourage in depth scientific investigation into prooxidant EMOD disease protection and prevention. Scientific fact must supplant unsupported skepticism or flawed conclusions based on outdated data. While emphasizing hydrogen peroxide, this review is aimed at presenting the scientific facts regarding prooxidant EMOD health applications and cancer therapy. Based on the scientific literature currently available, EMOD use has significant potential benefits in the treatment of a wide range of human pathophysiologies. To deny the crucial role of hydrogen peroxide and prooxidant EMODs in normal metabolic processes and disease protection is to deny scientific truth.
Introduction

It is perhaps amongst the greatest biochemical wonders of evolution that the most crucial and widespread small molecular weight EMODs, which are purportedly the alleged “enemies within,” are ever present and essential occupants of the most sensitive biochemical control systems within obligate aerobic cells. They carry on continual cross talk with their chemical kin. The naïve notion (promulgated by the free radical theory), that EMODs are inherently toxic, is counterintuitive to very basis of the evolutionary concept itself. After all, following oxygen's arrival, they evolved with the cell, by the cell and for the cell. Logic and biochemical principles dictate that careful EMOD modulation could serve as a safe means of advancing disease protection or reversal and health promotion.

However, even with hydrogen peroxide, which is an abundant permeating cellular mediator, nonspecific inhibition or augmentation of its activities may lead to homeostatic derangements by exogenous or endogenous over- or under-production.

Refute the Old Unproven Allegation: Free Radicals are Bad, Antioxidants are Good

In discussing the history of oxidants, such as hydrogen peroxide, respected free radical research pioneer, Barry Halliwell, said that, “In the beginning, it was simple: we said free radicals are bad, antioxidants are good.” However, much has changed and over half a century later, these unfounded charges remain unproven. Further, the free radial theory, upon which this was based, has failed to be verified by the scientific method because of its lack of predictability. In fact, recent findings from randomized controlled trials (RCTs) have repeatedly failed to support the free radical theory and some trial results have even shown harmful effects and increased risk of mortality from antioxidant use.

Following the 1992 US National Cancer Institute research for testing of beta carotene, Halliwell, from the National University of Singapore, said, “It was a shock. It (beta carotene) not only did no good but had the potential to do harm.” Subsequently, an expert panel convened by the National Institutes of Health has concluded that there is no evidence to recommend beta carotene supplements for the general population, and strong evidence to recommend that smokers avoid it.

The story was the same with vitamin E, in which recent studies have been almost universally “disappointing.” Further, in 2005, Dr. Edgar Miller of the Johns Hopkins Medical Institutions, published a meta-analysis review of 19 studies in Annals of Internal Medicine showing that vitamin E increased overall mortality. 1 Even though vitamin E appeared to be a good antioxidant in vitro, there is now serious scepticism that it acts in the same manner in vivo. 2

Following a large RCT on vitamin C, Halliwell said, “Vitamin C is another disappointment. People are still trying to defend it, but you don't get an effect on free radical damage unless you start with people with a vitamin C deficiency. I think it is a lost cause.”

Yet, the prevailing prejudice against EMODs is manifestly illustrated in the November 2003 issue of Readers Digest. In quoting Dr. Bruce Ames, a biochemist at the University of California at Berkley, he stated, “free radical oxidation doesn’t just rise with aging--it causes it. The more that mitochondria ‘leak’ free radicals (i.e., oxygen radicals, EMODs), the more those radicals end up damaging the mitochondria, which in turn leak even more free radicals.” In bold print, the article states, “The ultimate irony: The thing we need most to live--oxygen--is what’s killing us.” Statements such as this, which appear in both the lay press and in scientific publications, point out the currently accepted dogma which states that oxygen and its radicals are highly toxic, even lethal. To the contrary, the overall data shows that these conclusions are, at best, dubious.

History of the Flawed Free Radical Theory

In Science in 1954, Rebeca Gerschman and her colleagues first introduced the notion that free radicals are toxic agents. Gerschman published a paper entitled, “Oxygen poisoning and X-irradiation: a mechanism in common.” This paper led to the supposed link between oxygen free radicals and cellular damage, which was later used as the basis for the free radical theory of aging and oxidative stress. In 1956, over 53 years ago, Dr. Denham Harman proposed the free radical theory of aging. The free radical theory of aging simply argues that aging results from the accumulated damage generated over time by EMODs (oxygen free radicals). 3

Harman’s theory stated that the aging process resulted from the “stochastic” or random accumulated damage caused by EMODs (reactive oxygen species, ROS), many of which are products of normal cellular metabolism. 4-7

The mitochondrial electron transport chain (ETC) is an integral player because up to 10% of the reducing equivalents from NADH so-called “leak” to form superoxide anions and H2O2, although this is admittedly one of the highest “guestimates” of superoxide production by the ETC. 8 The commonly quoted range for EMOD ETC production is between 1-5%. The negative opinions regarding EMODs have changed from seeing reactive oxygen species (ROS) and redox states as only sources of damage, to viewing them as integral components in signal transduction. 9

EMODs and the redox state act as messengers in the intricate regulation of gene expression in development, growth, and apoptosis and there is widespread scientific support for the emerging perspective that EMODs are signaling molecules crucial in numerous cellular functions that are under precise control.

EMODs and Cancer Therapy

Cancer treatments using hydrogen peroxide have been around for decades and have been referred to as some of the following: hyperoxygenation, oxymedicine, oxidative therapy, bio-oxidative therapy and oxydology. The older literature based the use of hydrogen peroxide therapy on the work of Otto Warburg, M.D. (two time Nobel Prize in Medicine recipient), who believed that cancer cells grew best and primarily in an environment with hypoxic conditions. A simplistic view of Warburg’s advocates was that the administration of hydrogen peroxide, which is an oxygen-rich solution, would restore the proper oxygen balance and selectively attack and kill cancer cells. The website for the University of California, San Diego Medical Center (Moores Cancer Center) states, “According the American Cancer Society (ACS), there is no scientific evidence that hydrogen peroxide is a safe, effective or useful cancer treatment.” (Accessed 9-4-09).

A review of the scientific literature is essential to evaluate the accuracy or veracity of the ACS assessment, regarding the use of hydrogen peroxide for therapeutic purposes. Such a review rebuts their assertion.

Even though there has been “the poisoning of the oxidative watering hole” by the free radical theory for over a half century, world orthodoxy is now acknowledging that EMODs, inclusive of hydrogen peroxide, are of crucial benefit and play a central role in pathogen and neoplasia protection and cellular signaling. 10

Hydrogen Peroxide (H2O2)

How could the magnanimous wisdom of evolution produce a ubiquitous, omnipresent, allegedly highly damaging, powerful, toxic agent such as the accused hydrogen peroxide molecule, which, by design, is freely mobile and highly permeable through biological membranes, enabling its diffusion out of and within the cell from any intracellular production site? Such a case would defy scientific and evolutionary logic.

Hydrogen peroxide (H2O2) is a well-documented and essential component of aerobic living cells. It plays crucial roles in host defense and oxidative biosynthetic reactions. In addition there is growing evidence that at low levels, H2O2 also functions as a signaling agent, particularly in higher organisms. All aerobic organisms studied to date, from prokaryotes to humans, appear to tightly regulate their intracellular H2O2 concentrations at levels favorable to healthy homeostasis, i.e., 10-9 to 10-7M. 11

Well defined biochemical pathways involved in the response to exogenous H2O2 have been described in both prokaryotes and yeast. In animals and plants, many regulated enzymatic systems generate H2O2. In addition oxidation-dependent steps in signal transduction pathways are being uncovered, and evidence is accumulating regarding the nature of the EMOD type(s) involved in each of these pathways. Application of physiologic levels of H2O2 to mammalian cells has been shown to stimulate biological responses and to activate specific biochemical pathways in these cells. 12

Oxidation serves as our first line of defense and occurs with the respiratory burst, which should more properly be referred to as a “peroxide spike,” secondary to spontaneous or enzymatic dismutation of the superoxide anion. 13 Ergo, our lives are sustained, at least in part, by an innate “prooxidant-cure” and during times of need, to fight invaders or tumors, we rely on this “peroxide-spike” or “Vis medicatrix naturae” (The Healing Power of Nature). Thus, hydrogen peroxide is a formidable and influential orthomolecular agent.

Disruption of the delicate balance between prooxidants and antioxidants has been implicated in the pathophysiology of many chronic diseases, such as atherosclerosis, cancer, diabetes, strokes, arthritis and cataract formation 14 Unfortunately, far too frequently, we have been “radically misled,” regarding the overstated toxicity of EMODs. (see “The Howes Selective World Library of Oxygen Metabolism,” available at www.thepundit.com). 15, 16

Prooxidants are fundamental for life and the concentrations of electronically modified oxygen derivatives (EMODs) are important signaling agents, possibly extending to virtually all cellular processes. Oxygen is an important signal in all major aspects of stem cell biology including proliferation and tumorigenesis, cell death and differentiation, self-renewal, and migration. 17 “Redox signaling” is achieved by discrete, localized redox circuitry rather than by so-called “oxidative stress.” 18

This realization represents a significant departure from traditional views that prooxidant EMODs are simply harmful by-products of normal oxidative metabolism or only a tool through which phagocytes accomplish antimicrobial action. With this paradigm shift comes the challenge of understanding how EMOD production is regulated and localized within cells in both normal and pathological circumstances. Current evidence supports a sustaining role for EMODs and a generalized “injury” and protective response in tissues and organs.

Hydrogen Peroxide Overview

The literature illustrates the wide variety of cells and the distribution of EMOD production in the living/breathing cell. This alone demonstrates their low toxicity and the important role of EMODs in aerobic cells and their wide distribution is a counter argument to their supposed pernicious activity. Noted biochemist, Barry Halliwell, said that, “Over a year, a human body makes 1.7 kilograms or 3.74# of EMODs, which is a conservative estimate.” This begs the question, “Thus, how toxic are EMODs?”

O2 .- and H2O2 are cellular signaling molecules and they change the behavior of proteins as diverse as transcription factors and membrane receptors by virtue of their ability to undergo redox reactions with the proteins with which they interact, converting -SH groups to disulfide bonds and changing the oxidation states of enzyme-associated transition metals.

Prevalent EMOD Presence

EMOD activity has been detected in a wide variety of different cells including mesangial cells, oocytes, Leydig cells, thyroid cells, adipocytes, tumor cells, red blood cells and platelets. O2 .- and H2O2 are manufactured by many cell types, encompassing fibroblasts, endothelial and vascular smooth muscle cells, neurons, ova, spermatozoa and cells of the carotid body. Superoxide anions and hydrogen peroxide also participate in the induction of hyperactivated motility and the acrosome reaction. 19

The carotid body is an organ located at the bifurcation of the common carotid artery that measures the oxygen tension of the blood and it produces hydrogen peroxide on a continual basis. 20

Halliwell claims that the gastrointestinal tract, especially the stomach, with its highly acidic environment, is constantly generating reactive oxygen species from food. “Every time you drink a cup of coffee it's a dilute bowl of hydrogen peroxide,” says Halliwell. The hydrogen peroxide is there because of the presence of the antioxidants – “antioxidants” is really just another way of saying reducing agent, which can react with oxygen in the water to produce hydrogen peroxide. 21

There is a surprising number of proteins whose operation depends upon the redox state of the cell and includes the general transcription factors NF-kappa B and AP-1 (jun/fos), as well as several transcription factors that induce the synthesis of proteins that protect against so-called oxidative stress (e.g., soxR, soxS, oxyR).

Yet, some have come to view oxygen as a dangerous gift: indispensable for energy production but the alleged cause of damage that accumulates slowly over a lifetime. 22

Peroxide, the Terrible

Some say that under normal healthy conditions, 90% of H2O2 is generated as a toxic by-product of the mitochondrial electron transport chain (ETC) respiratory activity. 23, 24

In the past, some believed that H2O2, which is long lived and highly biomembrane permeable, must be immediately neutralized at the site of production to prevent diffusion throughout the cell or to the extracellular space. 25 Specific enzyme systems exist expressly for this purpose. These H2O2 neutralizing anti-oxidant enzymes are catalase (E.C. 1.11.1.6) and glutathione peroxidase (GPx, E.C. 1.11.1.9) with GPx responsible for 91% of H2O2 consumption. 26

Even more alarming, some believe that, if allowed to accumulate, H2O2 will diffuse from its site of production and generate hydroxyl radical (•OH), which is the most damaging and chemically reactive radical formed by cellular metabolism. They believe that the hydroxyl radical will indiscriminately destroy everything it encounters. 27-29

The hydroxyl radical is believed to be principally responsible for the cytotoxic effects of oxygen in animals. 29
Hydrogen Peroxide’s Crucial Role in Normal Cellular Function

Oxygen is the ultimate electron acceptor and reacts with all elements in the periodic table except the noble gases, which have no known biological function. The mitochondrial ETC is not perfect and up to 5% of electrons fail to combine with oxygen to produce water. 27 These so-called “leaked” electrons combine directly with molecular oxygen in the immediate vicinity, instead of the next carrier in the chain, to form the superoxide (O2-•) radical. 30

Likely, complex I and III, of the ETC, are the source of so-called electron leakage leading to the eventual intracellular generation of hydrogen peroxide. 31, 32 This ETC “leakage” or metabolic reduction of triplet O2 during cellular respiration produces superoxide anion (O2 .-), which is spontaneously or enzymatically dismutated to the prooxidant, H2O2,within mitochondria by the enzyme superoxide dismutase (SOD). 27

H2O2 has a pervasive presence in cells and is continuously being produced by the plasma membrane, cytosol and different subcellular organelles including mitochondria, peroxisomes, endoplasmic reticulum, nucleus and by almost 100 enzyme systems. 23, 25

Studies have determined that H2O2 is a small, diffusible, and ubiquitous molecule that can be synthesized, modified and/or destroyed rapidly in response to external stimuli, it meets all of the important criteria for an intracellular messenger, and H2O2 is now firmly established as a ubiquitous intracellular messenger under subtoxic conditions. 33-36

As previously mentioned, metabolic reduction of triplet O2 during cellular respiration produces superoxide anion radical (O2 .-), which is spontaneously or enzymatically dismutated to the prooxidant, non-radical, H2O2. Varying cell types produce low levels of O2 .- and H2O2 in response to a variety of extracellular stimuli, including cytokines (TGF-β1, TNF-α, and IL), peptide growth factors (PDGF; EGF, VEGF, bFGF, and insulin), the agonists of heterotrimeric G protein–coupled receptors (GPCR; angiotensin II, thrombin, lysophosphatidic acid, sphingosine 1-phosphate, histamine, and bradykinin), and shear stress. Research continues to uncover additional important sources of hydrogen peroxide in aerobic cells.

Hydrogen peroxide (H2O2) is present in exhaled breath and condensate and is produced by airway epithelia. Additionally, H2O2 is a vital substrate for the airway lactoperoxidase (LPO) anti-infection system. Duox is the major NADPH oxidase expressed in airway epithelia and therefore a contributor of H2O2 production in the airway lumen. 37

Although specific levels of ubiquitous H2O2 have been debatable, animals and humans have between 5.0 and 41 microM for aqueous humor and 115 and 187 microM for urine. 38, 39

Again, this begs the question, “Just how toxic are EMODs?”

It was believed that oxidative stress was the hallmark of asthma and increased levels of oxidants, such as H2O2 were considered a marker of the inflammatory process. In contrast to this notion, current studies suggest that hydrogen peroxide serves a role in suppressing both mucus production and airway hyper-responsiveness. 40

Hydrogen peroxide production has also been found in the nucleus of epithelial cells and it could convey redox signals altering gene expression. 41, 42 H2O2 is a natural orthomolecular substance and has been detected in serum and in intact liver. 43

In mouse pancreatic beta cells, H2O2 hyperpolarizes the cell membrane coupled with an increase of cell membrane conductance. 44

Moreover, it has recently been shown that H2O2:

increases intracellular Ca2+

decreases the ATP/ADP ratio

and inhibits glucose-stimulated insulin secretion from isolated mouse islets. 45

H2O2 as an Insulin Mimetic

Long ago, it was demonstrated that polyamines are able to exert insulin-like effects in fat cells through the production of hydrogen peroxide. 46

Hydrogen peroxide is now known to cause the reversible inhibition of protein tyrosine phosphatases (PTP) in cells, thereby strengthening insulin signaling. It has also been shown that production of hydrogen peroxide chemically in cells acts as an insulin mimetic. H2O2 improves glucose utilization in diabetics. Membrane receptors and transporters, including the insulin receptor and receptors for certain neurotransmitters, are regulated by the redox state of the cell.

Pancreatic β-cells are extremely sensitive to oxidative stress because of the low expression and activity of antioxidant enzymes. The GSH/GSSG (reduced/oxidized glutathione) ratio in islets is low compared with other tissues. 47

A 10-6-09 article by Tony Tiganis in the journal Cell Metabolism shows that “mice that lacked the antioxidant enzyme Gpx1 were less likely to develop insulin resistance -- an early sign of diabetes -- than normal mice. But when they treated the enzyme-deficient mice with an antioxidant, they lost this advantage and become more diabetic.” Tiganis said, “Our work suggests that antioxidants may contribute to early development of insulin resistance, a key pathological hallmark of type 2 diabetes.”

Other Roles for Peroxide

Hydrogen peroxide is only one of the many components that help regulate the amount of oxygen getting to cells. Its presence is vital for many other functions as well. It is required for the production of thyroid hormone and sexual hormones. Even the synthesis of thyroxin depends on the requirements of a H2O2 substrate for thyroid peroxidase and it stimulates the production of interferon.

A role for EMODs in controlling oxygen-sensitive channel function in excitable cells has been demonstrated previously. Hydrogen peroxide is capable of activating potassium transport pathways in excitable cells and in alveolar epithelial cells. These data suggest that EMODs and the hydroxyl radicals, formed from O2 in close vicinity to the cell membrane, play an important role in the oxygen-dependent activation of the K+-Cl- co-transporter. 48

H2O2 is produced by the autooxidation of ascorbic acid (vitamin C) and catecholamines, such as dopamine, norepinephrine and serotonin. 49

Amazingly, H2O2 is generated at a rate of 1.36 +/- 0.2 microM/h (3.9 +/- 0.6 nmol.h-1.g Hb-1), and a steady-state red blood cell concentration of H2O2 which is approximately 2 x 10(-10) M. Kinetic comparisons of H2O2 production and oxyhemoglobin autooxidation (which generates O2 .- that dismutases to H2O2) suggests that the latter is the main source of H2O2 in red blood cells. 50

Apparently, many articles and agencies are unaware of peroxide’s prime importance because studies have shown that the addition of exogenous H2O2, or its intracellular production in response to receptor stimulation, affects the function of various proteins, including protein kinases, protein phosphatases, transcription factors, phospholipases, ion channels, and G proteins.

EMODs can induce cellular senescence and apoptosis and can therefore function as anti-tumorigenic species. 51

Another 100+ articles related to hydrogen peroxide’s varied roles, including apoptosis, can be found at: http://www.caspases.org/showcitationlist.php?keyword=hydrogen%20peroxide%20h2o2,

Copyright © 2004-2007 ICMG Ltd. Medical literature citations obtained from the National Center for Biotechnology Information. Protein database information obtained from the European Bioinformatics Institute. Accessed 10-7-09.
H2O2 can Dilate Arteries

H2O2 can dilate blood vessels in the heart and brain. Mechano-sensitive mechanisms that are sensitive to deformation, pressure, stretch, and wall shear stress elicit release of NO and H2O2, resulting in reactive dilation of isolated coronary arterioles. 52

On June 23, 2009, the Medical College of Wisconsin received a four year, $1.5 million grant from the National Institutes of Health’s National Heart, Lung and Blood Institute to study the role of naturally produced hydrogen peroxide in controlling human blood flow. Dr. David Gutterman’s lab has observed a unique relationship between dilation in heart blood vessels from patients with coronary artery disease and the endothelial production of hydrogen peroxide and thus far, the association of vessel dilation with mitochondrial hydrogen peroxide has only been reported in human hearts.
EMOD Induced Apoptotic Cancer Cell Death

Cancer accounts for nearly 25% of all human deaths and no definitive cure is available as yet. 53 The most common treatment modalities promising a cure appear to be a combination of radiotherapy and chemotherapy and these methods, in part, utilize the reactivities of prooxidant EMODs, including hydrogen peroxide. Radiation exposure leads to the hydrolysis of water, thereby generating EMODs, which initiate chemical peroxidative processes that destroy biomolecules. 54

The postulated mechanism of action for many forms of chemotherapy, radiation therapy, photodynamic therapy, ozone therapy, hyperbaric oxygen therapy, intravenous mega-dose of vitamin C, the Howes singlet oxygen cancer therapy system and hydrogen peroxide therapy is the generation of electronically modified oxygen derivatives (EMODs). The production of EMODs leads to the stimulation of various signaling pathways, and in particular, stress-responsive signal transduction pathways are strictly regulated by the intracellular redox state. 55, 56

High level acute H2O2 treatment of various cells in vitro leads to apoptosis. 57

However, some investigators believe that hydrogen peroxide can cause apoptosis via a non-apoptotic pathway. Recent studies in a variety of cell types have suggested that cancer chemotherapy drugs induce tumor cell apoptosis in part by inducing formation of reactive oxygen species (EMODs). Investigators demonstrated that, at least in B lymphoma cells, chemotherapy-induced apoptosis occur using a mechanism that does not involve oxidants. Hydrogen peroxide, which reportedly kills cells by a non-apoptotic pathway, caused increases in both protein and lipid oxidation. 58

Hydrogen Peroxide and Hydroxyl Radical Antineoplastic Cytotoxicity

The cytotoxicity of the antineoplastic quinones doxorubicin, mitomycin C, and diaziridinylbenzoquinone for the Ehrlich ascites carcinoma can be significantly reduced or abolished by the antioxidant enzymes catalase and superoxide dismutase, the hydroxyl radical scavengers dimethyl sulfoxide, diethylurea, and thiourea, and the iron chelators deferoxamine, 2,2-bipyridine, and diethylenetriaminepentaacetic acid. Furthermore, treatment of intact tumor cells with doxorubicin, mitomycin C, and diaziridinylbenzoquinone required hydrogen peroxide, iron, and intact tumor cells. These results suggest that drug-induced hydrogen peroxide and hydroxyl radical production has a role in the antineoplastic action of redox active anticancer quinones. 59

Photodynamic Therapy (PDT) and Singlet Oxygen

Photodynamic therapy (PDT) is a novel approach for destruction of malignant cells and involves the administration of nontoxic dyes known as photosensitisers (PS) either systemically or topically, followed by illumination of the lesion with visible light (usually red). 60 The PS absorbs the light, and in the presence of oxygen, transfers the energy, thereby producing cytotoxic oxygen species (either singlet oxygen or oxygen radicals, i.e., EMODs). 61, 62

This reportedly leads to a rapid tumoricidal response mediated by both direct tumor cell toxicity and photodamage to the involved microvasculature and cellular structure. 63

Investigations have demonstrated that apoptotic and necrotic pathways are both involved in PDT-mediated cell death. 60, 64

A wide distribution of early response genes, genes associated with signal transduction pathways and cytokine expression, as well as stress response genes, are activated by PDT and primarily singlet oxygen. 65-71

EMODs can Have Complex Interactions

Interestingly, EMODs can react and interact to produce a family of products. For example, superoxide can react with itself to produce hydrogen peroxide or it can undergo univalent reduction to form hydrogen peroxide. Superoxide can react with the hydroxyl radical to produce singlet oxygen. Superoxide can also react with nitric oxide (NO.) (also a radical) to produce peroxynitrate (OONO-). Singlet oxygen can react with superoxide to produce hydrogen peroxide. Hydrogen peroxide can react with hypohalous acid to produce singlet oxygen. Hydrogen peroxide, in the presence of metal ions, can react to form a hydroxyl radical (HO.) and the hydroxide ion (HO-). Ozone can react with water to form hydrogen peroxide. Methylene blue and superoxide dismutase produce H2O2. Ascorbate can react with singlet oxygen and produce hydrogen peroxide.

Examples of the cross reactivity of EMODs illustrate the generation of a family of EMODs from the more basic EMOD agents (superoxide, hydrogen peroxide and singlet oxygen).

A Role for Hydrogen Peroxide in the Pro-apoptotic Effects of Photodynamic Therapy

Although the first EMOD formed during irradiation of photosensitized cells is almost invariably singlet molecular oxygen, 1O2 *, other EMODs have been implicated in the phototoxic effects of photodynamic therapy. Among these are superoxide anion radical (O2 .- ), hydrogen peroxide (H2O2) and hydroxyl radical (OH.). Investigators studied the role of H2O2 in the pro-apoptotic response to PDT in murine leukemia P388 cells. A primary route for detoxification of cellular H2O2 involves the peroxisomal enzyme catalase. Inhibition of catalase activity by 3-amino-1,2,4-triazole led to an increased apoptotic response. PDT-induced apoptosis was impaired by addition of an exogenous recombinant catalase analog (CAT-skl) that was specifically designed to enter cells and more efficiently localize in peroxisomes. A similar effect was observed upon addition of 2,2'-bipyridine, a reagent that can chelate Fe(+2), a co-factor in the Fenton reaction that results in the conversion of H2O2 to the hydroxyl radical (OH). These results provide evidence that formation of H2O2 during irradiation of photosensitized cells contributes to PDT efficacy. 72

H2O2, O2 .- and OH. are Involved in Phototoxic Tumoricidal Action

Researchers estimated the participation of EMODs, other than singlet oxygen (1O2 *), in the antitumor effect of PDT with hematoporphyrin derivative (HPD) as well as determined the ability of photoexcited HPD to the formation of protein peroxides that are regarded as a new form of EMOD. Experiments indicated that H2O2 and oxygen radicals could mediate the tumoricidal action of HPD-PDT; they found that photosensitization of EAC cells with HPD leads to the formation of significant amounts of H2O2, superoxide (O2 .-) and hydroxyl (OH.) radicals, which along with 1O2 * were involved in photoinactivation of the cells in vitro. Their data showed that in EAC cells subjected to HPD-PDT, the generation H2O2, O2 .- and OH. could be largely mediated by: (i) an increase in the activity of xanthine oxidase (XOD), due most probably to the conversion of xanthine dehydrogenase (XDH) to XOD via a Ca2+-dependent proteolytic process as well as oxidation of SH groups in XDH; and (ii) photooxidation of some cellular constituents (proteins). Another interesting finding of their studies was that in tumor cells subjected to HPD-PDT the Fenton-like reactions could play an important role in the generation of OH., and that cell-bound Cu/Zn-superoxide dismutase as well as catalase can protect tumor cells against the phototoxic action of HPD. They clearly demonstrated the ability of photoexcited HPD to the generation of protein peroxides in tumor cells. Studies suggest that 1O2 * is the main agent responsible for the generation of protein peroxides in EAC cells treated with HPD-PDT, although other EMODs (H2O2, O2 .- and OH.) were also implicated in this process. 73

Photofrin® is a purified form of hematoporphyrin derivative; it is a photosensitizer used in the treatment of cancer. Upon exposure to light it produces singlet oxygen, a highly electrophilic species that initiates oxidations that lead to cell death. 74, 75

Interestingly, singlet oxygen reacts readily with ascorbate, producing hydrogen peroxide. 76, 77

Ubiquitous and Omnipresent H2O2

The biochemistry of H2O2 is also, to a considerable extent, the biochemistry of the superoxide anion. Superoxide anion (O2 .-) converts rapidly to H2O2 either spontaneously or with the help of one of the superoxide dismutase enzymes (i.e., CuZnSOD, EcSOD, MnSOD, etc.). Since many of the EMODs are rapidly converted and/or transformed into other EMOD types, it also serves as a source of a large family of EMOD agents.

The two primary metabolic EMODs are O2 .- and H2O2. O2 .- is the primary stoichiometric precursor of H2O2 but considerable H2O2 can be produced directly and not via the superoxide anion.

Chance, et al. reviewed the metabolism of H2O2 in mammalian systems. 11

Though controversial, many papers still state that the mitochondria are the major cellular source of hydrogen peroxide. The amount of H2O2 produced by brain mitochondria is up to 5% of the amount of O2 consumed. H2O2 may be produced directly as a product of biological oxidations, or it may be produced by the dismutation of superoxide. The relative estimates of subcellular sources of H2O2 are as follows:

Endoplasmic reticulum (mixed function oxidations) 45%

Peroxisomes (metal-catalyzed oxidations) 35%

Mitochondria (oxidative phosphorylation) 15%

Cytosol (xanthine oxidation) 5%

These EMOD agents are formed continuously in all aerobic cells, either via oxygen energy metabolism, through reactions with drugs or toxins or via metabolism of fatty acids.

In 1999, Juan and Buettner calculated the steady state (ss) levels to be as follows:

[H2O2]ss in red cells is 10-10 M

[H2O2]ss in mitochondrial membrane is 10-8 M

[H2O2]ss in liver cells is 10-8 M

[O2]ss is 10-5 M, much higher than [H2O2]

[O2.-]ss in cells is 10-10 M

An additional source of O2 .− and H2O2 is the NADPH oxidase families (NOX and DuOX), which are found on various cellular membranes. Once thought to be restricted only to phagocytes, stimulated H2O2 production is now known to occur in almost all cells through NOX and/or DuOX activities. Thus, H2O2 has been accused of contributing to pathology through its reaction with transition metals that produce hydroxyl radicals via the Fenton reaction. Yet, even though it is not discussed, two hydroxyl radicals can combine to form hydrogen peroxide. This could well represent another salutary pathway for peroxide formation and pathogen and neoplasia defense.

H2O2 is involved in the generation of hypohalous acids through catalysis by myeloperoxidases and lactoperoxidase. These oxidizing acids are capable of killing microorganisms and allegedly causing tissue damage during inflammation. Ubiquitous H2O2 acts as a secondary messenger in signal transduction through its reaction with key proteins containing critical cysteine residues. 78, 79

Yet, the antioxidant, cysteine, itself can undergo autoxidation and form H2O2. This is somewhat analogous to the prooxidant EMOD activity of ascorbic acid.

The most common prooxidant in vivo is H2O2 and under inflammatory conditions, it is abundantly formed by dismutation of O2 .- released from activated phagocytes and other enzymatic systems, 80 but physiologically also by intracellular NADPH oxidases. 81

Although some H2O2 appears to be produced constitutively, receptor-mediated H2O2 formation appears to be more common. Typical examples are TNFa-induced mitochondrial O2 .- formation, 82 or cytoplasmic increase of H2O2 upon growth factor receptor stimulation. 83 Nonetheless, H2O2 is argued to be the most common prooxidant in vivo.

In a study on synergism between tumor necrosis factor-alpha and H2O2, levels of cellular toxicity were found. With PC12 tumor cells, TNF alpha toxicity was seen at >50 ng/ml, and that of H2O2 at > 150 microM. However, when together, sub-lethal levels (25 ng/ml TNF alpha and 30 microM H2O2) induced toxicity. 84

Please remember that the chemistry of superoxide is also the chemistry of hydrogen peroxide. Once activated, phagocytes produce large quantities of superoxide, on the order of 10 nmol.min-1.106 neuutrophils-1 during the oxidative burst. 80

The rate of superoxide production in vascular cells is thought to be ~1-10% of that in leukocytes. 85, 86 Basically, all cells continuously form O2 .- and submitochondrial particles generate O2 .- at a rate of 4-7 nmol/min-1/mg protein-1. 11

Superoxide anion can be viewed as an innate pathway for hydrogen peroxide production. Thus, EMODs are intentionally being generated to serve as salutary cellular products intended to help regulate critical metabolic and reproductive mechanisms. 87 These prooxidant EMODs stimulate numerous transcription factors as well as signaling cascades via activation of kinases and inhibition of tyrosine phosphatases.

Under physiological conditions, the intracellular production of EMODs does not alter the redox state of cells which have large reserves of reducing agents, notably reduced glutathione, as well as extremely effective antioxidant defense mechanisms, such as SOD, catalase, and peroxidases. This allows agonist-induced increases in EMODs to function as second messengers by limiting their effecting time and space in a manner similar to other well-known intracellular signals, such as cyclic AMP or nitric oxide. 88

Differing from O2 .− that is charged, hardly permeable, and extremely short-lived, H2O2 is uncharged, relatively longer-lived, and freely diffusible. This property makes H2O2 an ideal signaling molecule. Clearly, this illustrates the great importance of H2O2, in combination with other EMODs, in the regulation of cellular homeostasis and redox status. Under basal conditions, human cells produce about 2 X 109 (2 billion) O2.- and H2O2 molecules per cell per day. 89

EMODs are recognized as controlling key steps in cellular signal transduction cascades. 90, 91 EMODs can reversibly control gene expression and regulation at non-cytotoxic doses. 92 More specifically, there is evidence that hydrogen peroxide, H2O2, can modulate cellular functions through altering signal transduction in many cell types, including endothelial cells (ECs), vascular smooth muscle cells (VSMC), and T cells. 93-97

In fact, H2O2 is now widely recognized as a ubiquitous intracellular messenger, under subtoxic conditions. 23, 34, 35, 36, 98-100 As of 2000, at least 127 genes and signal transducing proteins had been reported to be sensitive to reductive and oxidative (redox) states in the cell. 92 That number, as of 2009, now exceeds 200.
EMODs Kill Cancer

Otto Warburg was the primary scientist to implicate oxygen in cancer. 101 Anaerobic metabolism is favorable to many pathogenic organisms and hypoxia is the predominant condition within neoplastic cells. Hypoxia has been closely associated with pathological processes. 102 Requiring adequate oxygen levels, many anticancer drugs and radiation kill cancer cells by inducing prooxidant EMOD apoptosis. 103

High level acute H2O2 treatment of various cells in vitro leads to apoptosis, with the involvement of NADPH oxidase isoforms and Src family kinases. 104

The chemotherapeutic agents doxorubicin, mitomycin C, etoposide and cisplatin are superoxide generating agents and consequently hydrogen peroxide producers. 105

Bleomycin and doxorubicin are agents shown to produce prooxidant oxygen agents. 106

In reactions involving Fe(II) and oxygen, a so-called “activated” bleomycin species is generated that damages DNA through free radical intermediates. 107

Superoxide and hydrogen peroxide can also react with Fe(II) or Fe(III) bleomycin, respectively, to produce the activated form of the drug. DNA damage from bleomycin and ionizing radiation is similar in both induction and repair. 108 Several other anti-cancer drugs are known to bring about their tumoricidal actions by an EMOD dependent mechanism. A majority of the studies reported that adriamycin, mitocmycin C, etc., augment EMOD production (superoxide anion and hydrogen peroxide) and lipid peroxidation in vitro and in vivo. 109

The anti-estrogen tamoxifen, increasingly used alongside other breast cancer therapies, has also been shown to induce oxidative stress (EMOD production) within carcinoma cells in vitro. 110

Oxygen levels are important since radiotherapy and photodynamic therapy generate oxygen radicals within the carcinoma cell. Thus, tumor hypoxia is a therapeutic concern since it can reduce the effectiveness of radiotherapy, some O2-dependent cytotoxic agents, and photodynamic therapy. 111
H2O2 Increases Doxorubicin Kill of Bladder Tumor Cells

Investigators determined whether the cytotoxicity of doxorubicin hydrochloride would be enhanced by adding hydrogen peroxide as a source of oxygen free radicals. Mouse bladder tumor cells (MBT-2) were grown in RPMI 1640 medium and treated with various concentrations of doxorubicin hydrochloride for 2 hours. They observed a dose dependent inhibition of MBT-2 cell growth after exposure to doxorubicin hydrochloride. Exposure to doxorubicin and hydrogen peroxide resulted in greater cell growth inhibition than exposure to either agent alone. The effects of hydrogen peroxide on cell proliferation were reversed by pre-incubation with alpha-tocopherol. As a source of oxygen free radicals, hydrogen peroxide enhances the antiproliferative effect of doxorubicin hydrochloride on a mouse bladder tumor cell line. 112

H2O2 Increases Sulindac Kill of Squamous Cell Carcinoma

A skin squamous cell carcinoma (SCC-25) cell line was utilized and treated with sulindac prior to exposure to tert-butyl hydroperoxide (TBHP) or hydrogen peroxide for 2 hours. The combination of sulindac and TBHP enhanced the killing of the skin cancer cells. Sulindac combined with TBHP leads to markedly increased levels of intracellular EMODs in SCC cells.

A small group of patients with actinic keratoses (AKs), were treated with the combination of sulindac and hydrogen peroxide gels. The results revealed that 60% of the treated AKs responded to therapy by exhibiting a decrease in size or becoming not visible to the naked eye. In addition, 50% of the treated AKs showed no residual AK on histopathology specimens after skin biopsy at the end of the study. Researchers concluded that the combination of sulindac and TBHP or H2O2 significantly enhances the killing of SCC cells. 113

The Baylor Group Peroxide Experience

In the 1960s, a group of investigators at Baylor Medical School (the Baylor group) conducted ground breaking studies with hydrogen peroxide in the treatment of a wide range of disease conditions. Various investigators have studied the value of H2O2 and shrinking the size of tumors, 114 and have studied treatment advantages and increased tumor cytotoxicity by the use of regional H2O2 infusion. 115

Earlier work indicated that hydrogen peroxide, a secretory product of mononuclear phagocytes, 116 accounts for a considerable portion of their nonphagocytic lysis of tumor cells in at least three circumstances: when certain secretagogues were added, when antitumor antibody was present, or when the tumor cells were coated with eosinophil peroxidase. 117

Many clinical and experimental applications of hydrogen peroxide have been demonstrated by the Baylor group. In over 300 patients regional intra-arterial hydrogen peroxide has potentiated the effect of radiation therapy in situations of malignancy involving the head, neck, pelvis and retro-peritoneum. 118

Increased localization of radioactive isotopes in malignant tumors has been achieved by regional and intra-arterial infusion of hydrogen peroxide. 119, 120

Granulocytes also secrete H2O2, which may participate in their cytotoxic effects in a variety of conditions. Preformed or enzymatically generated H2O2, with or without a peroxidase, lyses tumor cells, which was shown by Nathan’s group and others. 121-127

Reports have suggested that hydrogen peroxide released by mononuclear phagocytes and neutrophils may extend the antimicrobial, antitumor, and oxidant-injury activities of these cells to adjacent tissues. 128, 129

Nathan devised a nontoxic way to deliver hydrogen peroxide to sites of malignancy in vivo and to test its antitumor efficacy. Glucose oxidase was chosen for this purpose because its substrates, glucose and oxygen, are abundant in the body fluids and because its sole products are H2O2 and gluconic acid. 130 Glucose oxidase was coupled covalently to polystyrene microspheres (GOL) produced H2O2. Injection i.p. prolonged the survival of mice by 27% after injection of 106 P388 lymphoma cells in the same site, consistent with destruction of 97.6% of the tumor cells. Placing mice for several hours in 100% O~, the probable rate-limiting substrate for GOL, afforded a 42% prolongation of survival from P388 lymphoma, consistent with destruction of 99.6% of the tumor cells. A single injection of preformed H2O2 readily killed P388 cells in the peritoneal cavity, but only at doses nearly lethal to the mice. In contrast, GOL had very little toxicity. Thus, an H2O2-generating system confined to the tumor bed exerted clear-cut antitumor effects with little toxicity to the host.

Studies demonstrated that a combination of sub-lytic concentrations of chemically generated NO and H2O2 leads to death of murine lymphoma cells, in part, via induction of apoptosis. 131 In vitro studies have suggested that a reaction of nitric oxide (NO) gas and H2O2 produces singlet oxygen (which is the primary cytotoxic agent in PDT) or hydroxyl radicals. 132, 133 Nevertheless, this has not yet been demonstrated in cell cultures.

Others Argue That EMODs May Inhibit Apoptosis


In the past, the main focus of the importance of EMODs in oncology was that these agents were capable of inducing DNA damage, which could theoretically lead to cellular proliferation and a predisposition to cancer.

Even though an overwhelming accumulation of intracellular EMODs can create an oxidatively stressed environment leading to necrosis, a slight increase is a stimulus for cellular proliferation. 134, 135 Burdon et al interpreted this to mean that sublethal oxidative stress promotes cell proliferation in vitro, with both superoxide and hydrogen peroxide stimulating growth. Proliferation in response to hydrogen peroxide may be due to the activation of mitogen-activated protein kinases (MAPKs). HeLa cells treated with hydrogen peroxide undergo a sustained activation of all three MAPK pathways: extracellular signal related protein kinase; c-Jun amino-terminal kinase/stress-activated protein kinase; and p38.

However, Howes believes that a more logical explanation may be that an EMOD insufficiency “allows” for cell proliferation. 15

Theoretically, the carcinogenic process in animal models involves initiation and promotion. Allegedly, the production of EMODs and hydrogen peroxide occurs with several known tumor promoters, including 12-O-tetradecanoylphorbol-13-acetate (TPA), okadaic acid (OA), thapsigargin, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and H2O2., as well as peroxisome proliferators, steroidal estrogens, phenobarbital, chlordane and aroclor. However, their specific mechanism of action is evasive and speculative. 136

Severe oxidative stress leads to apoptosis. Conversely, persistent oxidative stress at sublethal levels may cause resistance to apoptosis. The induction of programmed cell death by EMODs is dependent on p53 in both mouse and human cell lines. 137 Current studies indicating a possible mechanism whereby H2O2 could promote tumor formation is sparse. 138 Further, many of these studies were carried out using non-physiological levels of H2O2, which can have cytotoxic activity.

However, this is in contrast to the work of others, who state that O2 .- and H2O2 do not react with DNA bases at all. 139 Yet, the hydroxyl radical (OH.) generates a variety of products from all four DNA bases and this pattern is used as a diagnostic “fingerprint” of OH. attack. 140

Singlet oxygen selectively attacks guanine to produce the 8-hydroxyguanine (8-OHG), which is also used as an index of oxidative damage to DNA and it can be measured as the nucleoside, 8-hydroxydeoxyguanosine (8-OHdG).

Some investigators believe that H2O2 may act as a “genotoxicant” or “epigenetic” agent and act as a promoting agent. However, even if hydrogen peroxide could cause DNA damage, peroxide is at best a very weak mutagen in mammalian cells. 136

Some endogenous DNA damage arises from intermediates of oxygen reduction that either attack the bases or the deoxyribosyl backbone of DNA. Yet, the study of oxidative DNA damage and its role in carcinogenesis is still controversial. 141

The International Agency for Research on Cancer (IARC) has determined that hydrogen peroxide is not classifiable as to its carcinogencity to humans. Even though accusations against H2O2 have been wide spread, there is no verified data, in man, that H2O2 in any way causes or promotes cancer in vivo. The WHO-IARC said, “There is inadequate evidence in humans for the carcinogenicity of hydrogen peroxide.”

Hyperoxia

Under conditions of hyperoxia, mitochondrial EMOD generation increases as a linear function of the oxygen tension. 142 Oxygen is critical to aerobic metabolism, but excessive oxygen (hyperoxia) can cause cell injury and death. An oxygen-tolerant strain of HeLa cells, which proliferates even under 80% O2, termed “HeLa-80,” was derived from wild-type HeLa cells (“HeLa-20”) by selection for resistance to stepwise increases of oxygen partial pressure. Unpredictably, antioxidant defenses and susceptibility to oxidant-mediated killing do not differ between these two strains of HeLa cells. However, under both 20 and 80% O2, intracellular reactive oxygen species (EMODs) production is significantly (~2-fold) less in HeLa-80 cells. In both cell lines the source of EMODs is evidently mitochondrial. Although HeLa-80 cells consume oxygen at the same rate as HeLa-20 cells, they consume less glucose and produce less lactic acid. Most importantly, the oxygen-tolerant HeLa-80 cells have significantly higher cytochrome c oxidase activity (~2-fold), which may act to deplete upstream electron-rich intermediates responsible for EMOD generation. Indeed, preferential inhibition of cytochrome c oxidase by treatment with n-methyl protoporphyrin (which selectively diminishes synthesis of heme a in cytochrome c oxidase) enhances EMOD production and abrogates the oxygen tolerance of the HeLa-80 cells. Thus, it appears that the remarkable oxygen tolerance of these cells derives from tighter coupling of the electron transport chain and reduced EMOD production. 143

Vitamin C

The ultimate agent to treat cancer would be cytotoxic only to tumor cells and non-toxic to normal cells. Vitamin C has been theorized to meet these requirements but has been criticized by conventional medicine in favor of more powerful and toxic chemotherapeutic agents. 144 Riordan found that at a dose of 7.04 mg/dl, vitamin C is completely toxic to cancer cells while being completely non-toxic to normal cells. Only at eight times the dose needed to kill cancer cells does vitamin C become toxic to normal cells. This reveals its considerable clinical potential. 145

Metabolically, vitamin C produces dehydroascorbate (DHA), an oxidant. Normal cells take in DHA, which is then converted to ascorbate and H2O2, by an oxidation/reduction (redox) electron transfer. Benade et al at the National Cancer Institute found that, in Ehrlich ascites carcinoma cell cultures, vitamin C selectively destroyed cancer cells by generating excess intracellular H2O2. 146

It has been observed for a long time that ascorbic acid and ascorbic acid salts are preferentially toxic to tumor cells, which were thought to be related to intracellular generation of hydrogen peroxide. 147-149 It is theorized that cancer cells are less able than normal cells to neutralize H2O2 because they are deficient in catalase. Dr. Agus et al reported that cancer cells have extra glucose channels that rapidly bring in glucose and excess DHA. 150

Cancer cells are defective in that they cannot fully distinguish between glucose and DHA. This may explain why vitamin C is safe in large doses for normal cells but toxic to cancer cells. The good results of Cameron and Hoffer with humans confirm the National Cancer Institute lab tests.

Mark Levine’s group published a study on line for PNAS on September 12, 2005, with results showing that, “Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues.” Human lymphoma cells were studied because of their sensitivity to ascorbate (EC50 of 0.5 mM) and suitability for evaluating mechanisms. Extracellular, but not intracellular, ascorbate resulted in cell death, which occurred by apoptosis and pyknosis/necrosis. Cell death was independent of metal chelators and absolutely dependent on H2O2 formation. 151

Investigators stated that it was not known why it killed cancer cells but not normal cells. They felt that it was possible the hydrogen peroxide caused damage that was repaired in normal cells but not in sensitive cancer cells. The main mechanism thought to be responsible for this is the lack or relative deficiency of catalase in tumor cells. 152

Therefore, it takes a smaller amount of H2O2 to reach or “trigger” apoptosis. This is the point of selectivity for toxicity to cancer cells, wherein there is no harm to normal cells. Interestingly, there is a reported 10- to 100-fold greater content of catalase in normal cells than in tumor cells. 146

Humans lack gulonolactone oxidase, which is necessary to synthesize vitamin C and H2O2 is produced as a by-product in the process. It is incredibly ironic, that in the synthesis of one of the most touted of all of the antioxidants, ascorbate, that “dreaded H2O2” is generated stochiometrically on a molecule per molecule basis. This illustrates the fact that H2O2 is very important in maintaining homeostasis within the cell and as a secondary messenger and that antioxidants and prooxidants may be considered to be flip sides of the same redox coin.

H2O2 Induced Apoptosis in Human Gastric Cancer Cells

Investigations were made into the molecular mechanism by which ascorbic acid (AA) induces apoptosis in human gastric cancer cells, AGS cells. High concentration (more than 5mM) of AA increased cellular iron uptake by increasing transferrin receptor (TfR) expression and induced AGS cell apoptosis which was inhibited by catalase. Interestingly, p38 mitogen-activated protein kinase (MAPK) inhibitor inhibited the upregulation of TfR and increased cell survival by AA. TfR-siRNA-transfected cells reduced apoptosis by AA. H2O2 increased TfR expression in AGS cells. Taken together, investigators concluded that high concentration of AA, through H2O2, induces apoptosis of AGS cells by p38-MAPK-dependent upregulation of TfR. 153

H2O2 Regulation of T Cells

The immune system is vital to protect us against infectious agents (bacteria, viruses, fungi, protozoans and cancer). Patients with T Cell immunodeficiencies are prone to infections and to certain types of cancers, especially leukemias and lymphomas.

There is evidence that T cells themselves produce H2O2 upon stimulation of their antigen receptor. 154, 155 A potential source for the unique production of H2O2 is the T cell receptor itself. This proposal comes from studies with isolated antibodies, which have the ability to catalyze a light-dependent reaction between molecular oxygen and water that leads to the production of H2O2. 156, 157

These events occur in all antibodies, regardless of source or antigenic specificity. The reaction is initiated by singlet oxygen that reacts with H2O to ultimately produce H2O2 via intermediates such as H2O3 and ozone. 158

...continued next post....
 
H2O2 Safety

The Food & Drug Administration (FDA) in Federal Regulation Vol. 46, Number 6, Jan 9, 1981, in effect gave the food industry a green light to use hydrogen peroxide in the “Aseptic” packaging process. The FDA has further ruled that hydrogen peroxide can be used in the processing of cheese and related cheese products (part 133), eggs and egg products (part 160), and as an anti-microbial agent in whey processing. They have also ruled it to be used in cleaning and healing mouth injuries and as a mouthwash (1% to 3% food grade H2O2).

As previously stated, “The International Agency for Research on Cancer (IARC) has determined that hydrogen peroxide is not classifiable as to its carcinogencity to humans. Even though accusations against H2O2 have been wide spread, there is no verified data, in man, that H2O2 in any way causes or promotes cancer in vivo.” The WHO-IARC said, “There is inadequate evidence in humans for the carcinogenicity of hydrogen peroxide.”

Information from the Hazardous Substances Data Bank (HSDB), a database of the National Library of Medicine’s TOXNET system (http://toxnet.nlm.nih.gov) indicates in general, ingestion, ocular or dermal exposure to small amounts of dilute hydrogen peroxide will cause no serious problems.

In 5 persons who accidentally drank 50 mL of a 33% H2O2 solution (not the readily available 3%), symptoms included stomach and chest pain, retention of breath, foaming at the mouth and loss of consciousness. Later, motor and sensory disorders, fever, micro-hemorrhages and moderate leukocytosis were noted. Still, all recovered completely within 2-3 weeks. 159 Yet, it may rarely be the cause of accidental death. 160

A review by Howes found a total of 13 deaths due to the accidental or intentional use of H2O2 in the entire history of recorded medical literature available on the internet. 16

Compare the record of safety with hydrogen peroxide with that of pharmaceutical drugs, which kill 12 per hour, every hour of the day, for 365 days a year (106,000/year). A 2000 report published in the Journal of the American Medical Association by Barbara Starfield, M.D., MPH reported that drugs kill over 106,000 annually, as a conservative estimate. 161

Pravda has discussed the possible role of hydrogen peroxide in the induction of ulcerative colitis secondary to non-physiological concentrations of peroxide used in peroxide enemas. 162

Caveat: Some references do not provide access to the original article or to an abstract. Most of the references available to Howes on the internet do not go beyond 1979. Thus, there may be cases of which I am unaware. Many of the articles concerning ingestion or infusion of peroxide are non-conclusive. Clinical histories are incomplete and documentation is scanty. One thing for certain is that many cases of over-zealous or accidental ingestion of concentrated hydrogen peroxide (20-40%) have had a surprisingly uneventful recovery. Actually, the ingestion or infusion of 3% H2O2 has resulted in very few patients who developed serious complications or severe outcomes.

A retrospective review of all exposures reported to a regional poison center over a 36 month period and found that of 95,052 exposures reported, 325 (.34%) were due to hydrogen peroxide. The pediatric population (< 18 years) accounted for 71% of hydrogen peroxide exposures and ingestion was the most common route of exposure (83%). Nausea and vomiting were the most common symptoms secondary to ingestion. Ocular and dermal exposures to dilute solutions resulted in transient symptoms without permanent sequelae. While most exposures by all routes resulted in a benign outcome (no effect or minor effect), there was a trend toward more severe outcomes in those who ingested a concentration greater than 10% (p = 0.011). 163 (Division of Emergency Medicine, University of Utah School of Medicine, Utah Poison Control Center, Salt Lake City).

Reports have described levels of H2O2 over 50 M as being cytotoxic for a wide range of plants and animal cells in vitro, but is dependent upon many factors such as, pH, media used, cell type used, length of exposure, etc. Paradoxically, acatalasemia in humans appears to produce no significant phenotype, nor does “knockout” of glutathione peroxidase in mice except under conditions of “abnormally high oxidative stress.” This is contrary to the teachings of the free radical theory and consistent with Howes’ Unified Theory. 164
Discussion

It is important to reemphasize the fact that antioxidants have repeatedly failed to prevent, control or reverse cancer and a host of so-called oxidative stress diseases. Thus, the free radical theory lacks predictability and consequently, according to the scientific method, it is unfounded. It is inexcusable that researchers continue to incriminate EMODs as only deleterious, noxious or mutagenic agents. In vitro studies may have little resemblance to the events occurring in living/breathing cells, which have considerable EMOD levels omnipresent.

Previously, investigators suggested that anything which served as an antioxidant was good and anything which oxidized something else was bad. That has repeatedly been proven to be untrue. All antioxidants can serve as prooxidants of greater or lesser reactivity. Further, H2O2 is now well recognized as an important and widespread second messenger for all aerobic cells. Based on scientific investigations, implying or giving the false impression that the presence of H2O2 is categorically bad is another example of unfounded and erroneous reporting.
Rethinking the Free Radical Theory

Any critical evaluation of EMODs must address the misconceptions propagated by the free radical theory of oxidative stress and aging. Hard data has yielded the following: 15

high levels of the antioxidant bilirubin cause kernicterus and permanent brain damage

the antioxidant β-carotene increases the rate of lung cancer development in smokers

the antioxidant CoQ, ubiquinone, when deleted from the diet of C. elegans, increases its lifespan

SOD/catalase mimetics decrease the lifespan of house flies

the antioxidant α-tocopherol, vitamin E, increases the rate and number of heart attacks and strokes

high levels of the antioxidant, uric acid, cause gout and cardiovascular disease

acatalasemic patients live basically normal lives

Many molecules are designed to accept and receive electrons as a natural part of their reactivity, especially the transitions metals and the heme proteins. Oxygen’s various modified derivatives, electronic configurations and states, are the primary agents that protect us from infections and neoplastic growths throughout our lives, from conception to death. Report after report shows that mitochondria play a crucial role in apoptosis. 165

A growing body of evidence favors the involvement of intracellular reactive oxygen species (EMODs) at some point during apoptotic execution. 166-170 Apoptosis is carried out by a multistage chain of reactions in which EMODs act as triggers and essential mediators. 171, 172 The level of lipid peroxidation in patients with cancer was significantly reduced compare with that in healthy control subjects. 173 The lower level of lipid peroxidation in the cancer patients may be indicative of low EMOD levels, which would allow for the development of cancer.

Even death signaling by anticancer drugs generally relies on positive input from the mitochondria, as is evidenced by the resistance of tumor cells over-expressing the death-inhibitory protein Bcl-2 that is localized to the membranes of mitochondria, endoplasmic reticulum, and nucleus. 174-176 Repeatedly, the critical role of cellular redox status in the regulation of death signaling has been demonstrated. 177-180

These findings become more important considering the critical role of the mitochondria during apoptosis and the fact that mitochondria have been implicated directly as a prime source of EMODs during drug-induced apoptosis. 181-183 As the mitochondria are a major source of intracellular EMODs, it is tempting to speculate that EMODs, such as H2O2, may function both upstream and downstream of the mitochondria. Tumor cells lacking Bax (Bax–/–) are resistant to the effect of some anti-cancer drugs. 184

Analysis of subcellular distribution of Bax (in HCT116, HL60, and CEM cells) revealed that Bax redistributed to the mitochondrial fraction from the cytosol on exposure to H2O2, which could be significantly blocked by the H2O2 scavenger, catalase.

Recruitment of Bax to the mitochondria during apoptotic signaling has been linked to the activation of upstream caspase 8 and caspase 8-mediated cleavage of the proapoptotic protein Bid. This is particularly true on ligation of death receptors, such as CD95 (Apo1/Fas). Additionally, H2O2 and anticancer drugs have been shown to up-regulate the expression of the CD95 receptor or its ligand (CD95L) in some systems. 185, 186

Investigators utilized the ability of certain anticancer drugs to increase intracellular production of EMODs, specifically H2O2. 187 Indeed, exposure of HCT116 Bax+/– or HL60 cells to a novel anticancer compound C1 resulted in an increase in intracellular H2O2 and translocation of Bax to the mitochondria. This translocation of Bax was inhibited by catalase, thus establishing the critical role of intracellular H2O2 in mitochondrial recruitment during drug-induced apoptosis of tumor cells. These data indicate that Bax translocation triggered in tumor cells during drug (C1)-induced apoptosis was a direct result of intracellular H2O2 production, independent of the upstream caspase 8 or ceramide pathways. 187

Cytosolic Acidification

Cytosolic acidification is an early event in apoptosis and provides an intracellular milieu permissive for efficient death execution. In this regard, exposure of cells to H2O2 or drugs that trigger intracellular increase in H2O2 results in a significant drop in cytosolic pH. 187

Accordingly, signals that inhibit apoptotic acidification impede death signaling as demonstrated in a recent study. 188 Investigators results provided strong evidence that the link between H2O2 and Bax translocation could be the drop in cytosolic pH brought about by exposure of cells to exogenous H2O2 or endogenous production of H2O2 on drug exposure. It is possible that this indicates the pivotal role of H2O2 in cancer cell killing or apoptotic execution.

This shows that apoptosis is likely initiated with EMOD production, especially H2O2. H2O2 is, for the most part, essential for cancer killing and a shift to an acidic intracellular environment may also aid in its tumoricidal activity and the production of other agents within the EMOD family. Studies demonstrated the ability of commonly used chemotherapeutic drugs vincristine and daunorubicin to trigger an early increase in intracellular H2O2. 188

Pro-oxidant intracellular milieu is a hallmark of many tumor cells and is believed to endow tumor cells with a survival advantage over their normal counterparts. 189, 190 It has been shown previously that maintaining a slightly elevated intracellular O2 - promotes cellular proliferation 135 and inhibits apoptotic signaling. 191 Fortunately, this is one specific feature which provides us with an opportunity to selectively kill cancer cells by increasing EMOD levels even further.

Many investigators have demonstrated the critical role of intracellular H2O2 in rendering the cytosolic milieu permissive for efficient apoptotic execution. 169, 170, 192 Further, these data strongly support and underscore the critical role of H2O2 in creating a permissive intracellular milieu for efficient drug-induced execution of tumor cells. 193
Dicumarol Increased EMODs Killing Human Pancreatic Cancer Cells

Dicumarol is a naturally occurring anticoagulant derived from coumarin that induces cytotoxicity and oxidative stress in human pancreatic cancer cells. Dicumarol

increased intracellular levels of superoxide (O2 -. ), as measured by hydroethidine staining, and inhibited cell growth. 194 Mitochondrial production of EMODs mediates the increased susceptibility of cancer cells to dicumarol-induced cytotoxicity. 195

MnSOD Overexpression and Inhibition of H2O2 Removal Increases Cancer Cell Cytotoxicity

Overexpression of manganese superoxide dismutase (MnSOD) and inhibition of H2O2 removal, increases cancer cell cytotoxicity. Investigators hypothesized that increasing endogenous O2 .- production in cells that were pretreated with adenoviral MnSOD (AdMnSOD) plus 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) would lead to an increased level of intracellular H2O2 accumulation and increased cell killing. The cytotoxic effects of Adriamycin or radiation, agents known to produce O2 .-, were determined in MDA-MB-231 breast cancer cells pretreated with AdMnSOD plus BCNU both in vitro and in vivo. In vitro, AdMnSOD plus BCNU sensitized cells to the cytotoxicity of Adriamycin or radiation. In vivo, AdMnSOD, BCNU, and Adriamycin or ionizing radiation inhibited tumor growth and prolonged survival. Thus, agents that produce O2 .- in combination with AdMnSOD plus BCNU may represent a powerful new antitumor regimen against breast cancer. 196

Myeloperoxidase Involvement in H2O2-induced Apoptosis of HL-60 Human Leukemia Cells

Investigators examined the mechanism of H2O2-induced cytotoxicity and its relationship to oxidation in human leukemia cells. The HL-60 promyelocytic leukemia cell line was sensitive to H2O2, and at concentrations up to about 20-25 uM, the killing was mediated by apoptosis. When HL-60 cells were incubated with methimazole or 4-aminobenzoic acid hydrazide, which are inhibitors of myeloperoxidase, they no longer underwent H2O2-induced apoptosis. 197 This strongly supports the primary role of EMOD induced apoptosis in cancer cell cytotoxicity.
Antitumor Therapy via Enzymatic Generation of Hydrogen Peroxide

Investigators studied the antitumor activity of an H2O2-generating enzyme, D-amino acid oxidase (DAO), and its conjugate with polyethylene glycol (PEG; PEG-DAO). To generate cytotoxic H2O2 at the tumor site, PEG-DAO was first administrated i.v. to tumor-bearing mice. After an adequate lag time, the substrate of DAO, D-proline, was injected i.p. This treatment resulted in significant suppression of tumor growth.

PEG-DAO thus delivered together with D-proline produces remarkable antitumor activity via extensive generation of H2O2. 198

SOD Over Expression Increases Peroxide Levels and Suppresses Human Prostate Cancer Cells

Investigators studied the role of the antioxidant enzyme manganese superoxide dismutase (MnSOD) in androgen-independent human prostate cancer (PC-3) cells' growth rate in vitro and in vivo. Production of extracellular H2O2 was increased in the MnSOD-overexpressing clones. Results are consistent with MnSOD being a tumor suppressor gene in human prostate cancer. 199

This supports the assertion that prooxidant EMODs, such as H2O2, contribute to a continually functional oxidative protective system to curtail cancer growth. The increased SOD resulted in increased peroxide levels, which in turn suppressed tumor growth, via EMOD induced apoptosis.

Increased EMODs Increases Cancer Cell Cytotoxicity

Relative to normal cells, neoplastic cells demonstrate increased sensitivity to glucose-deprivation-induced cytotoxicity. To determine whether oxidative stress mediated by O2 .- and hydroperoxides contributed to the differential susceptibility of human epithelial cancer cells to glucose deprivation, the oxidation of DHE (dihydroethidine; for O2 .- ) and CDCFH(2) [5- (and 6-)carboxy-2',7'-dichlorodihydrofluorescein diacetate; for hydroperoxides] was measured in human colon and breast cancer cells (HT29, HCT116, SW480 and MB231) and compared with that in normal human cells [FHC cells, 33Co cells and HMECs (human mammary epithelial cells)]. HCT116 and MB231 cells were more susceptible to glucose-deprivation-induced cytotoxicity and oxidative stress, relative to 33Co cells and HMECs. HT29 cells were also more susceptible to 2DG (2-deoxyglucose)-induced cytotoxicity, relative to FHC cells. Overexpression of manganese SOD (superoxide dismutase) and mitochondrially targeted catalase significantly protected HCT116 and MB231 cells from glucose-deprivation-induced cytotoxicity and oxidative stress and also protected HT29 cells from 2DG-induced cytotoxicity. These results show that cancer cells (relative to normal cells) demonstrate increased steady-state levels of EMODs (reactive oxygen species; i.e. O2 .- and H2O2 ) that contribute to differential susceptibility to glucose-deprivation-induced cytotoxicity and oxidative stress. These studies support the hypotheses that cancer cells increase glucose metabolism to compensate for excess metabolic production of EMODs and that inhibition of glucose and hydroperoxide metabolism may provide a biochemical target for selectively enhancing cytotoxicity and oxidative stress in human cancer cells. 200

EMODs are Positive Signals in the Fruit Fly Immune System

The September 24, 2009 issue of the journal Nature, carried an article by Dr. Utpal Banerjee et al, UCLA’s Jonsson Comprehensive Cancer Center researchers found much to their surprise, that in Drosophila, the common fruit fly, moderately elevated levels of EMODs are a good thing. Banerjee said, “These small molecules act as an internal communicator, signaling certain blood precursor cells, or blood stem cells, to differentiate into immune-bolstering cells in reaction to a threat. After the progenitor cells differentiate, the EMOD levels return to normal, ensuring the safety and survival of the mature blood cells.”

Thus, he asks, “could excessive use of antioxidants deplete our immune systems?” Alleged;y, reducing levels of reactive oxygen is usually the goal, and what Banerjee found was surprising, in that when EMODs were taken away from the blood stem cells, they failed to differentiate into the immune-bolstering cells, called macrophages. On the other hand, when levels of EMODs were further increased by genetic means, the blood stem cells “differentiated like gang busters,” Banerjee said, making a large number of macrophages.

The EMODs, Banerjee said, acted as a signaling mechanism that kept the blood stem cells in a certain state - when levels rose, it was a message to the cell to differentiate. Keeping their EMOD levels slightly elevated puts the cells on alert, sensitized and ready to respond to any threat quickly.

That work prompted the obvious question: If fruit fly blood stem cells and mammalian blood stem cells operate in the same way, is it a good thing for people to be taking antioxidants? Are antioxidants dulling the immune system and its ability to react to threats? It is interesting, however, that these types of blood progenitors in mammals also give rise to macrophages, Banerjee said.

Banerjee said, “If we find that those blood stem cells aren't primed to respond because the ROS levels are reduced, that would not be a good thing. Our findings raise the possibility that wanton overdose of antioxidant products may in fact inhibit formation of cells participating in innate immune response.” Once again, this data emphasizes the crucial role of EMODs in aerobic cells. http://www.medicalnewstoday.com/articles/165268.php Accessed 9-25-09.
Just to Add Further Complications

Pro-senescent Effect of Hydrogen Peroxide on Cancer Cells and Tumor Suppression

Mild oxidative stress is known to induce premature senescence, termed stress-induced premature senescence (SIPS), in normal human diploid cells. Investigators determined whether mild oxidative stress would trigger SIPS in a human tumor cell line, human lung adenocarcinoma A549. The results showed that sublethal concentrations of H2O2 induced SIPS in A549 cells and consequently attenuated, but did not completely eliminate, the tumorigenicity of these cells. They next investigated the reasons for this incomplete impairment of tumorigenicity in A549 cells in SIPS. The results suggested that H2O2 treated A549 cells are composed of a heterogeneous cell population: one is sensitive to H2O2 and the other is resistant or undergoes reversal; the latter reverted to their original tumorigenic form. The molecular mechanisms determining the cellular fate of tumor cells in SIPS should be identified in order to make use of SIPS and oncogene-induced senescence in tumor cells as methods of tumor suppression. 201

Indirect Evidence for EMOD Induced Apoptosis Via Antioxidant Studies

The US is experiencing epidemics of cancer, diabetes, obesity and fatigue, which may be related to increased ingestion of antioxidant vitamins and dietary supplements, which are now commonly found as supplements or fortifiers of many foods and are aggressively marketed to an ever-growing segment of the population. These agents could be interfering with or modifying our continually operational prooxidant protective system.

Despite two decades of controversy regarding the use of dietary antioxidant supplementation during conventional chemotherapy and radiation therapy, questions remain about their efficacy and safety. However, on the basis of published randomized clinical trials, the use of supplemental antioxidants during chemotherapy and radiation therapy should be discouraged because of the possibility of tumor protection and reduced patient survival. 202

Several new reports are raising concerns about the safety and efficacy of vitamin and mineral supplements in healthy individuals and cancer patients and survivors. Some experts see a need for further studies; whereas, others say that there are sufficient negative data to stop vitamin trials altogether. 203

Significant in vitro data exists showing that antioxidants can block EMOD-induced apoptosis for a wide variety of cancerous cell types, such as leukemia, lymphoma, retinoblastoma, myeloma, pheochromocytoma and human cancers of the breast, lung, pancreas, liver, colon, rectum and endometrium. 204 This data can not be ignored.

However, it has recently been shown that EMODs may have an alternative activity, by modulating tumor cell signaling and that tumor cell signaling mediated by EMODs are readily reversible upon treatment with antioxidants. This emerging evidence may serve as bona fide signal transduction modifiers for cancer. A re-examination is warranted. 205

However, in the words of one investigator, “If you suppress free radicals, you suppress programmed cell death.” 206

One Final Note

Philipp Niethammer, Harvard Medical School postdoctoral researcher and biologist, accidentally discovered while analyzing the severed tail of zebrafish that the hydrogen peroxide in their wounds appeared in bursts at the wound about 17 minutes before the leukocytes that were supposed to be producing them appeared too. On 6-4-09, ScienceNow reported that hydrogen peroxide summons reinforcements from the immune system, and more specifically white blood cells, which in turn aid with the healing process. Please view the video of peroxide migration in the wound of a zebrafish http://www.youtube.com/watch?v=a7PJ8yXyPVU. “Hydrogen peroxide marshals immune system.” Accessed 10-9-09. This interesting video illustrates the rapid wound response and permeability of H2O2.

However, due to the complex nature of the interactions of EMODs and antioxidants within the body, it is difficult to clearly and definitively interpret the results of many experiments and observations.

Conclusion

Unarguably, EMODs are intricately, inextricably and crucially involved in cancer cell killing via their prominent role in apoptosis. Statements of the ineffectiveness in the killing of cancerous cells via hydrogen peroxide or other EMOD types are baseless, inaccurate and irresponsible. The lingering inaccuracies of the free radical theory must be countered by the obvious omnipresent and ubiquitous known salutary effects of the prooxidant EMODs. Their presence in steady state quantities testifies to their essential nature in healthy homeostasis and their low toxicity. EMODs, and especially hydrogen peroxide, are produced throughout the body in steady state levels on an as needed and when needed basis and serve to support the interrelated highly complex redox systems of the body. It is inconceivable that they only exist for pernicious purposes. Because of their relatively short half lives, their localized instantaneous concentrations can remain at low levels. Yet, their synthesis and availability can be called upon at any given moment to combat impending pathogens or neoplasia.

EMODs have bactericidal, fungicidal, virucidal and anti-protozoan and anti-neoplastic roles but also have far reaching cellular signaling control functions. The peroxide spike during the respiratory burst classically serves as a protective role against infectious pathogens, as does EMOD induced apoptosis to combat neoplasia. Hydrogen peroxide is likely the most ubiquitous member of the family of EMOD agents. Its important and prominent biochemical role is ever expanding.

References
1. Miller ER III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37-46.
2. Howes M.D., PhD., R. (2007). Antioxidant Vitamins A, C & E; Death in Small Doses and Legal Liability? PHILICA.COM Article number 89. Published April 5, 2007.
3. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 11: 298–300, 1956.
4. Harman, D., 1981. The aging process. Proc. Natl Acad. Sci. USA 78, 7124–7128.
5. Beckman, K.B., Ames, B.N., 1998. The free radical theory of aging matures. Physiol. Rev. 78, 547–581.
6. Finkel, T., Holbrook, N.J., 2000. Oxidants, oxidative stress and the biology of ageing. Nature 408, 239–247.
7. Balaban, R.S., Nemoto, S., Finkel, T., 2005. Mitochondria, oxidants, and aging. Cell 120, 483–495.
8. Marnett LJ, Riggins JN, West JD. Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J Clin Invest. 2003; 111: 583–593.
9. Darley-Usmar, V., Starke-Reed, P.E., 2000. Antioxidants: strategies for interventions in aging and age-related diseases, a workshop sponsored by the National Institute on aging and by the office of dietary supplements. Antioxid. Redox. Signal. 2, 375–377.
10. Howes R.M. The Free Radical Fantasy: A Panoply of Paradoxes. Ann. N. Y. Acad. Sci. 2006;1067:22-26.
11. Chance B, Sies, H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527-605.
12. Hydrogen Peroxide: A Signaling Messenger. James R. Stone, Suping Yang. Antioxidants & Redox Signaling. March/April 2006, 8(3-4): 243-270.
13. Howes, R. M. U.T.O.P.I.A. - Unified Theory of Oxygen Participation in Aerobiosis. © 2004. Free Radical Publishing Co. Kentwood, LA, available at www.iwillfindthecure.org.
14. Halliwell B. Oxidants and human disease: some concepts. FASEB J. 1987;1:358–364.
15. Howes, R.M. © 2005. The Medical and Scientific Significance of Oxygen Free Radical Metabolism. Free Radical Publishing Co. Kentwood, LA. available at www.iwillfindthecure.org.
16. Howes, R.M. Hydrogen Peroxide Monograph 1: Scientific, Medical and Biochemical Overview & Monograph 2: Antioxidant Vitamins A, C, & E: Equivocal Scientific Studies, © 2006. Free Radical Publishing Co. Kentwood, LA. available at www.iwillfindthecure.org.
17. Marie Csete. Oxygen in the Cultivation of Stem Cells. Ann. N.Y. Acad. Sci. 1049: 1–8 (2005.
18. Go YM, Gipp JJ, Mulcahy RT, and Jones DP. H2O2-dependent activation of GCLC-ARE4 reporter occurs by mitogen-activated protein kinase pathways without oxidation of cellular glutathione or thioredoxin-1. J Biol Chem 279: 5837–5845, 2004.
19. Aitken J, Fisher H. Reactive oxygen species generation and human spermatozoa: the balance of benefit and risk. Bioessays. 1994 Apr;16(4):259-67.
20. Acker H, Bolling B, Delpiano MA, Dufau E, Gorlach A & Holtermann G (1992). The meaning of H2O2 generation in carotid body cells for pO2 chemoreception. Journal of the Autonomic Nervous System, 41: 41-51.
21. Lisa Melton. The antioxidant myth: a medical fairy tale – from New Scientist. http://www.newscientist.com/article/mg19125631.500.html (5 August 2006) New Scientist. Pg. 40-43. volume 191; issue 2563.
22. B.M. Barbior. Superoxide: a two-edged sword. Braz J Med Biol Res, February 1997, Volume 30(2) 141-155.
23. Thannical VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1005-L1028.
24. Eaton JW, Qian M. Molecular basis of cellular iron toxicity. Free Radic Biol Med 2002; 32: 833-840.
25. Harman, D. 1957. Prolongation of the normal life span by radiation protection chemicals. J. Gerontol. 12: 257-263.
26. Boveris A, Cadenas E. Mitochondrial production of hydrogen peroxide regulation by nitric oxide and the role of ubisemiquinone. IUBMB Life 2000; 50: 245-250.
27. Eberhardt MK. Reactive Oxygen Metabolites: Chemistry and Medical Consequences. CRC Press 2001.
28. Chen S, Schopfer P. Hydroxyl radical production in physiological reactions. Eur J Biochem 1999; 260: 726-735.
29. Fridovich I. Oxygen toxicity: A radical explanation. J Exp Biol 1998; 20: 1203-1209.
30. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 2000; 29:222-230.
31. Lemasters J, Nieminen A. Mitochondria in Pathogenesis. Kluwer Academic/Plenum Publishers 2001: 281-286) 90.
32. St-Pierre, J., Buckingham, J.A., Roebuck, S.J. and Brand, M.D. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem 2002; 277:44784-44790.
33. Rhee SG, Bae YS, Lee SR, Kwon J: Hydrogen peroxide: A key messenger that modulates protein phosphorylation through cysteine oxidation. Science’s stke. Available at: www.stke.sciencemag.org/cgi/content/full/OC_sigtrans; 2000/53/pe1.
34. Rhee SG: Redox signaling: Hydrogen peroxide as intracellular messenger. Exp Mol Med 31: 53–59, 1999.
35. Finkel T: Oxygen radicals and signaling. Curr Opin Cell Biol 10: 248–253, 1998.
36. Suzuki YJ, Ford GD: Redox regulation of signal transduction in cardiac and smooth muscle. J Mol Cell Cardiol 31: 345–353, 1999.
37. Radia Forteza et al. Regulated Hydrogen Peroxide Production by Duox in Human Airway Epithelial Cells. American Journal of Respiratory Cell and Molecular Biology. Vol. 32, pp. 462-469, 2005.
38. Ramachandran S, Morris SM, Devamanoharan P, Henein M, Varma SD. Radio-isotopic determination of hydrogen peroxide in aqueous humor and urine. Exp Eye Res. 1991 Oct;53(4):503-6.
39. García-Castiñeiras S. Hydrogen peroxide in the aqueous humor: 1992-1997. P R Health Sci J. 1998 Dec;17(4):335-43.
40. Niki L. Reynaert et al. Catalase Overexpression Fails to Attenuate Allergic Airways Disease in the Mouse. The Journal of Immunology, 2007, 178: 3814-3821.
41. Li JM and Shah AM. (2002) Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 277:19952–19960.
42. Grandvaux N, Grizot S, Vignais PV, Dagher MC. (1999) The Ku70 autoantigen interacts with p40phox in B lymphocytes. J Cell Sci 112:Pt 4503–513.
43. IARC, 1985). (IARC. 1985. International Agency for Research on Cancer. Hydrogen Peroxide. In: IARC Monographs on the Evaluation of Carcinogenic Risk if Chemicals to Humans: Allyl compounds, Aldehydes, Epoxides and Peroxides, Vol. 36. IARC, Lyon, pp. 285-314.
44. Krippeit-Drews, P., Lang, F., Haussinger, D. and Drews, G. Pflugers. H2O2 induced hyperpolarization of pancreatic -cells. Pflügers Arch. 426: 552-554, 1994.
45. Krippeit-Drews, P., Kramer, C., Welker, S., Lang, F., Ammon, H.P. and Drews, G. Interference of H2O2 with stimulus-secretion coupling in mouse pancreatic β-cells. J Physiol (Lond) 1999; 514(Pt 2): 471-481.
46. Livingston J, Gurny P, Lockwood D: Insulin-like effects of polyamines in fat cells. Mediation by H2O2 formation. J Biol Chem 1977, 252:560-562.
47. Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radical Biology & Medicine. 1996;20:463–466.
48. Anna Yu Bogdanova and Mikko Nikinmaa. Reactive Oxygen Species Regulate Oxygen-sensitive Potassium Flux in Rainbow Trout Erythrocytes. The Journal of General Physiology, Volume 117, Number 2, February 1, 2001 181-190.
49. Halliwell B. Reactive oxygen species and the nervous system. 1992. J. Neurochemistry 59, 1609-1623.
50. C Giulivi, P Hochstein, KJ Davies. Hydrogen peroxide production by red blood cells. Free Radic Biol Med (1994) 16: 123-9.
51. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44-84.
52. Akos Koller and Zsolt Bagi. Nitric oxide and H2O2 contribute to reactive dilation of isolated coronary arterioles. Am J Physiol Heart Circ Physiol 287: H2461-H2467, 2004.
53. Balachandran P and Govindarajan R. Cancer—an ayurvedic perspective Pharmacol Res 2005; 51: 19–30.
54. Papa S and Shulachev VP. Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem 1997; 174: 305–19.
55. Matsuzawa A, Ichijo H. Stress-responsive protein kinases in redox-regulated apoptosis signaling. Antioxid Redox Signal. 2005;7:472–481.
56. Han H, Wang H, Long H, Nattel S, Wang Z. Oxidative preconditioning and apoptosis in L-cells. Roles of protein kinase B and mitogen-activated protein kinases. J Biol Chem. 2001;276:26357–26364.
57. Reinehr R, Becker S, Eberle A, Grether-Beck S, Haussinger D. Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem. 2005; 280(29):27179-27194.
58. Senturker, S., Tschirret-Guth, R., Morrow, J., Levine, R. and Shacter, E. Induction of apoptosis by chemotherapeutic drugs without generation of reactive oxygen species. Arch of Biochem and Biophy 2002; 397(2): 262-272.
59. J H. Doroshow. Role of Hydrogen Peroxide and Hydroxyl Radical Formation in the Killing of Ehrlich Tumor Cells by Anticancer Quinones. PNAS June 15, 1986, vol. 83, no. 12, 4514-4518.
60. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90: 889–905 .
61. Ochsner M (1997) Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol B 39: 1–18 .
62. Fisher A. M. R., Murphree A. L., Gomer C. J. Clinical, and preclinical photodynamic therapy. Lasers Surg. Med., 17: 2-31, 1995.
63. Henderson B. W., Dougherty T. J. How does photodynamic therapy work? Photochem. Photobiol., 55: 145-157, 1992.
64. Oleinick N. L., Evans H. E. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat. Res., 150: S146-S156, 1998.
65. Luna M. C., Wong S., Gomer C. J. Photodynamic therapy mediated induction of early response genes. Cancer Res., 53: 1374-1380, 1994.
66. Gollnick S. O., Liu X., Owczarczak B., Musser D., Henderson B. W. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res., 57: 3904-3909, 1997.
67. Tao J-S., Sanghera J. S., Pelech S. L., Wong G., Levy J. G. Stimulation of stress-activated protein kinase and p38 HOG1 kinase in murine keratinocytes following photodynamic therapy with benzoporphyrin derivative. J. Biol. Chem., 271: 27107-27115, 1996.
68. Gomer C. J., Luna M., Ferrario A., Rucker N. Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic stress or Photofrin II incubation. Photochem. Photobiol., 53: 275-279, 1991.
69. Gomer C. J., Ferrario A., Rucker N., Wong S., Lee A. Glucose regulated protein induction and cellular resistance to oxidative stress mediated by porphyrin photosensitization. Cancer Res., 51: 6574-6579, 1991.
70. Gomer C., Ryter S., Ferrario A., Rucker N., Wong S., Fisher A. Photodynamic therapy mediated oxidative stress can induce heat shock proteins. Cancer Res., 56: 2355-2360, 1996.
71. Curry P. M., Levy J. Stress protein expression in murine tumor cells following photodynamic therapy with benzoporphyrin derivative. Photochem. Photobiol., 58: 374-379, 1993.
72. Price M, Terlecky SR, Kessel D. A Role for Hydrogen Peroxide in the Pro-apoptotic Effects of Photodynamic Therapy. Photochem Photobiol. 2009 Jul 21.
73. Chekulayeva LV, Shevchuk IN, Chekulayev VA, Ilmarinen K. Hydrogen peroxide, superoxide, and hydroxyl radicals are involved in the phototoxic action of hematoporphyrin derivative against tumor cells. J Environ Pathol Toxicol Oncol. 2006;25(1-2):51-77.
74. Redmond RW, Gamlin JN. A compilation of singlet oxygen yields from biologically relevant molecules. Photochem. Photobiol. 1999;70:391–475.
75. Dysart JS, Patterson MS. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro. Phys. Med. Biol. 2005;50:2597–2616.
76. Buettner GR, Need MJ. Hydrogen peroxide and hydroxyl free radical production by hematoporphyrin derivative, ascorbate and light. Cancer Lett. 1985;25:297–304.
77. Galina G. Kramarenko, Stephen G. Hummel, Sean M. Martin, and Garry R. Buettner. Ascorbate Reacts with Singlet Oxygen to Produce Hydrogen Peroxide. Photochem Photobiol. 2006; 82(6): 1634–1637.
78. Henry Jay Forman. Hydrogen Peroxide: The Good, The Bad, and The Ugly. Contained in: Oxidants in Biology. Springer Netherlands. ISBN 978-1-4020-8398-3. 2008.
79. James R. Stone, Suping Yang. Hydrogen Peroxide: A Signaling Messenger. Antioxidants & Redox Signaling. March/April 2006, 8(3-4): 243-270.
80. Babior, B.M. NADPH oxidase: An update. Blood 1999; 93: 1464-1476.
81. Bayraktutan, U., Blayney, L. and Shah, A.M. Molecular characterization and localization of the NADPH oxidase components gp91-phox and p22-phox in endothelia cells. Arterioscler Thromb Vasc Biol 2000; 20: 1903-1911.
82. Goossens, V., Grooten, J., DeVos, K. and Fiers. W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA 1995; 92: 8115-8119.
83. Finkel, T. Redox-dependent signal transduction. FEBS Lett 2000; 476: 52-54.
84. Trembovler, V., Abu-Raya, S. and Shohami, E. Synergism between tumor necrosis factor-alpha and H2O2 enhances cell damage in rat PC12 cells. Neurosci Lett. 2003 Dec 19; 353(2):115-118.
85. Hohler, B.; Holzapfel, B., and Kummer W. NADPH oxidase submits and superoxide production in porcine pulmonary artery endothelial cells. Histochem Cell Biol 2000; 114: 29-37.
86. Rueckschloss, U. Galle, J., Zerkowski H. R. and Morawietz, H. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation 2001; 104: 1767-1772.
87. Signal Transduction by reactive Oxygen and Nitrogen Species: Pathways and Chemical Principles. Edited by H.J. Forman, J. Fukuto and M. Torres, Kluwer Academic Publishers, 2003.
88. Schafer, F. Q. and Buettner, G. R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001; 30: 1191-1212.
89. Hoidal, J.R. Reactive oxygen species and cell signaling. Am J Respir Cell Mol Biol 2001; 25: 661-663.
90. Schreck, R., Rieber, P. and Baeuerle, P.A. Reactive oxygen intermediates as apparently widely needed messengers in the activation of the NK-k B transcription factor and HIV-1. Embo J 1991; 10: 2247-2258.
91. Sen, C.K. and Packer, L. Antioxidant and redox regulation of gene transcription. Faseb J 1996; 10: 709-720.
92. Allen, R.G. and Tresini, M. Oxidative stress and gene regulation. Free Rad Biol Med 2000; 28: 463-499.
93. Los, M., W. Droege, K. Stricker, P. A. Baeuerle, K. Schulze-Osthoff. 1995. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur. J. Immunol. 25:159.
94. Harlan, J. M., K. S. Callahan. 1984. Role of hydrogen peroxide in the neutrophil-mediated release of prostacyclin from cultured endothelial cells. J. Clin. Invest. 74:442.
95. Lewis, M. S., R. E. Whatley, P. Cain, T. M. McIntyre, S. M. Prescott, G. A. Zimmerman. 1988. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J. Clin. Invest. 82:2045.
96. Sundaresan, M., Z-X. Yu, V. J. Ferrans, K. Irony, T. Finkel. 1995. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270:296.
97. Rao, G. N., B. C. Berk. 1992. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res. 70:593.
98. Griendling, K.K. and Ushio-Fukai, M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 2000; 91: 21-27.
99. Patel, R.P., Moellering, D., Murphy-Uhrich, J., Jo., H., Beckman, S. and Darley-Usmar, V.M. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Radic Biol Med 2000; 28: 1780-1794.
100. Forman, H.J. and Torres, M. Signaling by the respiratory burst in macrophages. IUBMB Life 2001; 51: 365-371.
101. Warburg, O. On the origin of cancer cells. Science 1956; 123: 309-314.
102. Einar K. Rofstad, Heidi Rasmussen, Kanthi Galappathi, Berit Mathiesen, Kristin Nilsen and Bjørn A. Graff. Hypoxia Promotes Lymph Node Metastasis in Human Melanoma Xenografts by Up-Regulating the Urokinase-Type Plasminogen Activator Receptor. Cancer Research 62, 1847-1853, March 15, 2002.
103. Hickman, J.A. Apoptosis induced by anticancer drugs. Cancer Metast Rev 1992; 11: 121-139.
104. Reinehr R, Becker S, Eberle A, Grether-Beck S, Haussinger D. Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem. 2005; 280(29):27179-27194.
105. Yokomizo A, Ono M, Nanri H, Makino Y, Ohga T, Wada M, Okamoto T, Yodoi J, Kuwano M, Kohno K. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res 1995;55:4293–4296.
106. Hasinoff B. B., Davey J. P. Adriamycin and its iron(III) and copper(III) complexes, glutathione-induced dissociation, cytochrome c oxidase inactivation and protection: binding to cardiolipin. Biochem. Pharmacol., 37: 3663-3669, 1988.
107. Burger R. M. Cleavage of nucleic acids by bleomycin. Chem. Rev., 98: 1153-1169, 1998.
108. Byfield J. E., Lee Y. C., Tu L., Kullhanian F. Molecular interactions of the combined effects of bleomycin and X-rays on mammalian cell survival. Cancer Res., 36: 1138-1143, 1976.
109. Sangeetha, P., Das, U.N., Koratkar, R. and Suryaprabha, P. Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic Biol Med 1990; 8(1): 15-19.
110. Ferlini C, Scambia G, Marone M, Distefano M, Gaggini C, Ferrandina G, Fattorossi A, Isola G, Benedetti Panici P, Mancuso S. Tamoxifen induces oxidative stress and apoptosis in estrogen receptor-negative human cancer cell lines. Br J Cancer 1999;79:257–263.
111. P. Vaupel and L. Harrison. Tumor Hypoxia: Causative Factors, Compensatory Mechanisms, and Cellular Response. Oncologist, November 1, 2004; 9(suppl_5): 4 – 9.
112. Loughlin KR; Manson K; Cragnale D; Wilson L; Ball RA; Bridges KR. The use of hydrogen peroxide to enhance the efficacy of doxorubicin hydrochloride in a murine bladder tumor cell line J Urol. 2001; 165(4):1300-4.
113. Lionel Resnick, Harold Rabinovitz, David Binninger, Maria Marchetti, Herbert Weissbach. Topical sulindac combined with hydrogen peroxide in the treatment of actinic keratoses. Journal of Drugs in Dermatology. January 1, 2009. Volume: 8 Issue: 1 Page: 29(4).
114. Aronoff, B.L. Regional oxygenation in neoplasms. Cancer 1965; 18: 1250.
115. Mallams, J.T., Balla, G.A. and Finney, J.W. Regional oxygenation and irradiation in the treatment of malignant tumors. Prog in Clin Cancer 1965; 1: 137.
116. Nathan, C. F., and R. K. Root. 1977. Hydrogen peroxide release from mouse peritoneal macrophages. Dependence on sequential activation and triggering.]. Exp. Med. 146:1648.
117. Nathan CF, Cohn ZA. Antitumor effects of hydrogen peroxide in vivo. J Exp Med. 1981 Nov 1;154(5):1539–1553.
118. Mallams, J.T., Balla, G.A. and Finney, J.W. Regional oxygenation and irradiation in the treatment of malignant tumors. Prog Clin Cancer 1965; 1: 137.
119. Finney, J.W., Collier, R.E., Balla, G.A., Tomme, J.W., Wakley, J., Race, G.J., Urschel, H.C., D’Errico, A.D. and Mallams, J.T. The preferential localization of radioisotopes in malignant tissue by regional oxygenation. Nature 1961; 202: 1172.
120. Finney, J.W., Balla, G.A., Collier, R.E., Wakely, J., Urschel, H.C. and Mallams, J.T. Differential localization of isotopes in tumors through the use of intra-arterial hydrogen peroxide: Part 1: Basic science. Amer J Roentgen 1965; 94: 783.
121. Nathan, C. F., L, H. Brukner, S. C. Silverstein, and Z. A. Cohn. 1979. Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J. Exp. Med. 149:84.
122. Philpott, G. W., W. T. Shearer, R. J. Bower, and C. W. Parker. 1973. Selective cytotoxicity of hapten-substituted cells with an antibody-enzyme conjugate. J. Immunol. 111:921.
123. Edelson, P. J., and Z. A. Cohn. 1973. Peroxidase-mediated mammalian cell cytotoxicity. J. Exp. Med. 138:318.
124. Clark, R. A., S. J. Klebanoff, A. B. Einstein, and A. Fefer. 1975. Peroxidase-H20-halide system: cytotoxic effect on mammalian tumor cells. Blood. 45:161.
125. Nathan, C. F. 1979. The role of oxidative metabolism in the cytotoxicity of activated macrophages after pharmacologic triggering. In Immunobiology and Immunotherapy of Cancer. W. D. Terry and Y. Yamamura, editors. Elsevier North-Holland, Inc., New York. 59.
126. Philpott, G. W., A. Kulczycki, Jr., E. H. Grass, and C. W. Parker. 1980. Selective binding and cytotoxicity of rat basophilic leukemia cells (RBL-1) with immunoglobulin E-biotin and avidin-glucose oxidase conjugates.J. Immunol. 125:1201.
127. Nathan, C. F., B. A. Arrick, H. W. Murray, N. M. DeSantis, and Z. A. Cohn. 1981. Tumor cell antioxidant defenses: inhibition of the glutathione redox cycle enhances macrophage mediated cytolysis.J. Exp. Med. 153:766.
128. Nathan CF, Brukner LH, Silverstein SC, Cohn ZA. Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J Exp Med. 1979 Jan 1;149(1):84–99.
129. Nathan CF, Silverstein SC, Brukner LH, Cohn ZA. Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J Exp Med. 1979 Jan 1;149(1):100–113.
130. Keilin, D., and E. F. Hartree. 1948. Properties of glucose oxidase (notatin). Biochem. J. 42:221.
131. Filep, J.G., Lapierre, C., Lachance, S. and Chan, J.S.D. Nitric oxide cooperates with hydrogen peroxide in inducing DNA fragmentation and cell lysis in murine lymphoma cells. Biochem J 1997; 321: 887-901.
132. Kanner, J., Harel, S. and Granit, R. Arch Biochem Biophys 1991; 289: 130-136.
133. Noronha-Dutra, A.A., Epperlein, M.M. and Woolf, N. FEBS Lett 1993; 321: 59-62.
134. Burdon R. H., Gill V., Rice-Evans C. Cell proliferation and oxidative stress. Free Radic. Res. Commun., 7: 149-159, 1989.
135. Burdon R. H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med., 18: 775-794, 1995.
136. Takeuchi,T., Matsugo,S. and Morimoto,K. (1997) Mutagenicity of oxidative DNA damage in Chinese hamster V79 cells. Carcinogenesis, 18, 2051–2055.
137. Yin Y, Solomon G, Deng C, Barrett JC. Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress. Mol Carcinog 1999;24:15–24.
138. Huang, et al, Tumor promotion by hydrogen peroxide in rat liver epithelial cells. Carcinogenesis, Vol. 20, No. 3, pp. 485-492, 1999.
139. Dizdaroglu, M. (1993) In DNA and Free Radicals (Halliwell, B., and Aruoma, O.I. eds.), pp. 19-39, Ellis Horwood, Chichester.
140. Halliwell, B. and Aruoma, O.I. DNA damage by oxygen-derived species. (1991) FEBS Lett. 281, 9-19.
141. L.J. Marnett. Oxyradicals and DNA damage. Carcinogenesis 2000 Mar;21(3):361-70.
142. Turrens, J.F. Mitochondrial formation of reactive oxygen species. (2003) Journal of Physiology-LONDON 552(2):335-344.
143. Campian, J.L., Qian, M., Gao, X., and Eaton, J.W. Oxygen tolerance and coupling of mitochondrial electron transport. 279(45): 46580-46587, 2004.
144. Riordan N, Riordan H and Casiari J. Clinical and experimental experiences with intravenous vitamin C. Journal of Orthomolecular Medicine, Special Issue: Proceedings from Vitamin C as Cancer Therapy Workshop, Montreal. 15(4): 201-13. 1999.
145. Riordan N et al. Intravenous ascorbate as a tumour cytotoxic chemotherapeutic agent. Medical Hypothesis. 9(2): 207-13. 1994.
146. Benade L, Howard T and Burke D. Synergistic killings of Ehrlich ascites carcinoma cells by ascorbate and 3 amino-1, 2, 4-triazole. Oncology. 1969;23:33-43.
147. Tsao C, Dungham B and Ping Y. In vivo antineoplastic activity of ascorbic acid for human mammary tumour. In vivo. 2: 147-50. 1988.
148. Bram S et al. Vitamin C preferential toxicity for malignant melanoma cells. Nature. 284: 629-31. 1980.
149. Matsuda, T., Kuroyanagi, M., Sugiyama, S., Umehara, K., Ueno, A. and Nishi, K. Role of hydrogen peroxide for cell death induction by sodium 5,6-Benzylidene-L-ascorbate. Chem Pharm Bull 1994; 6: 1216-1225.
150. Agus DB, Vera JC and Golde DW. Stromal cell oxidation: a mechanism by which tumors obtain vitamin C. Cancer Research. 1999;59:4555-4558.
151. Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, Shacter E, and Levine L. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues. PNAS. September 20, 2005. Vol. 102. No. 38. pp. 13604-13609.
152. Maramag C et al. Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability, and DNA synthesis. Prostate. 32: 188-95. 1997.
153. Ha YM, Park MK, Kim HJ, Seo HG, Lee JH, Chang KC. High concentrations of ascorbic acid induces apoptosis of human gastric cancer cell by p38-MAP kinase-dependent up-regulation of transferrin receptor. Cancer Lett. 2009 May 8;277(1):48-54.
154. Devadas S, Zaritskaya L, Rhee SG, Oberley L, Williams MS. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and Fas ligand expression. J Exp Med 195(1):59-70, 2002.
155. Williams MS, Kwon J. T cell receptor stimulation, reactive oxygen species and cell signaling. Free Rad Biol Med 37(8):1144-1151, 2004.
156. Wentworth et al., 2000) (Wentworth AD, Jones LH, Wentworth P Jr, Janda KD, Lerner RA. Antibodies have the intrinsic capacity to destroy antigens. PNAS 97(20):10930-10935, 2000).
157. Wentworth P Jr, Jones LH, Wentworth AD, Zhu X, Larsen NA, Wilson IA, Xu X, Goddard WA III, Janda KD, Eschenmoser A, Lerner RA. Antibody catalysis of the oxidation of water. Science 293 (5536):1806-1811, 2001.
158. Wentworth P Jr, Wentworth AD, Zhu X, Wislon IA, Janda KD, Eschenmoser A, Lerner RA. Evidence for the production of trioxygen species during antibody-catalyzed chemical modification of antigens. PNAS 100(4):1490-1493, 2003.
159. IARC. 1985. International Agency for Research on Cancer. Hydrogen Peroxide. In: IARC Monographs on the Evaluation of Carcinogenic Risk if Chemicals to Humans: Allyl compounds, Aldehydes, Epoxides and Peroxides, Vol. 36. IARC, Lyon, pp. 285-314.
160. Cina SJ, Downs JC, Conradi SE. Hydrogen peroxide: a source of lethal oxygen embolism. Case report and review of the literature. Am J Forensic Med Pathol. 1994 Mar;15(1):44-50.
161. Starfield, B. Is US Health Really the Best in the World? JAMA 2000 Jul 26;284[4]:483-5.
162. Jay Pravda. Radical induction theory of ulcerative colitis. J Gastroenterol April 28, 2005 April;11(16):2371-2384.
163. Dickson KF, Caravati EM. Abstract: Hydrogen peroxide exposure--325 exposures reported to a regional poison control center. J Toxicol Clin Toxicol. 1994;32(6):705-14.
164. Howes, R. M. U.T.O.P.I.A. - Unified Theory of Oxygen Participation in Aerobiosis. © 2004. Free Radical Publishing Co. Kentwood, LA Available at www.iwillfindthecure.org.
165. Kroemer, G., Zamzami, N. and Susin, S.A. Mitochondrial control of apoptosis. Immunol Today 1997; 18: 44-51.
166. Fleury C, Mignotte B, Vayssiere JL Mitochondrial reactive oxygen species in cell death signaling. Biochimie 2002;84:131-41.
167. Mansat-de Mas V, Bezombes C, Quillet-Mary A, et al Implication of radical oxygen species in ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicin. Mol Pharmacol 1999;56:867-74.
168. Simizu S, Umezawa K, Takada M, Arber N, Imoto M Induction of hydrogen peroxide production and Bax expression by caspase-3(-like) proteases in tyrosine kinase inhibitor-induced apoptosis in human small cell lung carcinoma cells. Exp Cell Res 1998;238:197-203.
169. Hirpara JL, Clement MV, Pervaiz S Intracellular acidification triggered by mitochondrial-derived hydrogen peroxide is an effector mechanism for drug-induced apoptosis in tumor cells. J Biol Chem 2001;276:514-21.
170. Clement MV, Ponton A, Pervaiz S Apoptosis induced by hydrogen peroxide is mediated by decreased superoxide anion concentration and reduction of intracellular milieu. FEBS Lett 1998;440:13-18.
171. Kerr, J.F.R., Winterfold, C.M. and Harmon, B.V. Apoptosis, its significance in cancer and cancer therapy. Cancer 1994; 73: 2013-2026.
172. Blackstone, N.W. and Green, D.R. The evolution of a mechanism of cell suicide. Bio Essays 1999; 21: 84-88.
173. Khyshiktyev BS, Khyshiktueva NA, Ivanov VN, Darenskaia SD, Novikov SV. Diagnostic value of investigating exhaled air condensate in lung cancer. Vopr Onkol 1994; 40: 161-164.
174. Tsujimoto Y., Shimizu S. VDAC regulation by the Bcl-2 family of proteins. Cell Death Differ., 7: 1174-1181, 2000.
175. Korsmeyer S. J. BCL-2 gene family and the regulation of programmed cell death. Cancer Res., 59: 1693-1700S, 1999.
176. Harris M. H., Thompson C. B. The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ, 7: 1182-1191, 2000.
177. Clement M. V., Pervaiz S. Reactive oxygen intermediates regulate cellular response to apoptotic stimuli: an hypothesis. Free Radic. Res., 30: 247-252, 1999.
178. Clement M. V., Pervaiz S. Intracellular superoxide and hydrogen peroxide concentrations: a critical balance that determines survival or death. Redox. Rep., 6: 211-214, 2001.
179. Pervaiz S., Clement M. V. Hydrogen peroxide-induced apoptosis: oxidative or reductive stress?. Methods Enzymol., 352: 150-159, 2002.
180. Pervaiz S., Clement M. V. A permissive apoptotic environment: function of a decrease in intracellular superoxide anion and cytosolic acidification. Biochem. Biophys. Res. Commun., 290: 1145-1150, 2002.
181. Fleury C, Mignotte B, Vayssiere JL Mitochondrial reactive oxygen species in cell death signaling. Biochimie 2002;84:131-41.
182. Childs AC, Phaneuf SL, Dirks AJ, Phillips T, Leeuwenburgh C Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res 2002;62:4592-8.
183. Quillet-Mary A, Jaffrezou JP, Mansat V, Bordier C, Naval J, Laurent G Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J Biol Chem 1997;272:21388-95.
184. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B Role of BAX in the apoptotic response to anticancer agents. Science 2000;290:989-92.
185. Hug H, Strand S, Grambihler A, et al Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem 1997;272:28191-3.
186. Suhara T, Fukuo K, Sugimoto T, et al Hydrogen peroxide induces up-regulation of Fas in human endothelial cells. J Immunol 1998;160:4042-7.
187. Hirpara JL, Clement MV, Pervaiz S. Intracellular acidification triggered by mitochondrial-derived hydrogen peroxide is an effector mechanism for drug-induced apoptosis in tumor cells. J Biol Chem 2001;276:514-21.
188. Ahmad KA, Clement MV, Hanif IM, Pervaiz S. Resveratrol inhibits drug-induced apoptosis in human leukemia cells by creating an intracellular milieu nonpermissive for death execution. Cancer Res 2004;64:1452-9.
189. Cerutti P. A. Prooxidant states and tumor promotion. Science (Wash. DC), 227: 375-381, 1985.
190. Burdon R. H., Gill V., Rice-Evans C. Oxidative stress and tumour cell proliferation. Free Radic. Res. Commun., 11: 65-76, 1990.
191. Fadeel B., Ahlin A., Henter J. I., Orrenius S., Hampton M. B. Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood, 92: 4808-4818, 1998.
192. Hampton M. B., Orrenius S. Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett., 414: 552-556, 1997.
193. Tze Wei Poh and Shazib Pervaiz. LY294002 and LY303511 Sensitize Tumor Cells to Drug-Induced Apoptosis via Intracellular Hydrogen Peroxide Production Independent of the Phosphoinositide 3-Kinase-Akt Pathway. Cancer Research 65, 6264-6274, July 15, 2005.
194. Cullen, J. J., Hinkhouse, M. M., Grady, M., Gaut, A. W., Liu, J., Zhang, Y., Weydert, C. J. D., Domann, F. E., and Oberley, L. W. (2003) Cancer Res. 63, 5513–5520.
195. Juan Du, David H. Daniels, Carla Asbury, Sujatha Venkataraman, Jingru Liu, Douglas R. Spitz, Larry W. Oberley, and Joseph J. Cullen. Mitochondrial Production of Reactive Oxygen Species Mediate Dicumarol-induced Cytotoxicity in Cancer Cells. The Journal of Biological Chemistry Vol. 281, No. 49, pp. 37416–37426, December 8, 2006.
196. Sun Wenqing; Kalen Amanda L; Smith Brian J; Cullen Joseph J; Oberley Larry W. Enhancing the antitumor activity of adriamycin and ionizing radiation. Cancer research 2009;69(10):4294-300.
197. Wagner B A; Buettner G R; Oberley L W; Darby C J; Burns C P. Myeloperoxidase is involved in H2O2-induced apoptosis of HL-60 human leukemia cells. The Journal of biological chemistry 2000;275(29):22461-9.
198. Jun Fang, Tomohiro Sawa, Takaaki Akaike and Hiroshi Maeda. Tumor-targeted Delivery of Polyethylene Glycol-conjugated D-Amino Acid Oxidase for Antitumor Therapy via Enzymatic Generation of Hydrogen Peroxide. Cancer Research 62, 3138-3143, June 1, 2002.
199. Venkataraman Sujatha; Jiang Xiaohong; Weydert Christine; Zhang Yuping; Zhang Hannah J; Goswami Prabhat C; Ritchie Justine M; Oberley Larry W; Buettner Garry R. Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene 2005;24(1):77-89.
200. Aykin-Burns Nùkhet; Ahmad Iman M; Zhu Yueming; Oberley Larry W; Spitz Douglas R. Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. The Biochemical Journal 2009;418(1):29-37.
201. Yoshizaki K, et al. Pro-senescent effect of hydrogen peroxide on cancer cells and its possible application to tumor suppression. Biosci Biotechnol Biochem. 2009 Feb;73(2):311-5.
202. Brian D. Lawenda, Kara M. Kelly, Elena J. Ladas, Stephen M. Sagar, Andrew Vickers, Jeffrey B. Blumberg. Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy? JNCI Journal of the National Cancer Institute 2008 100(11):773-783.
203. Vicki Brower. An Apple a Day May Be Safer Than Vitamins. JNCI Journal of the National Cancer Institute 2008 100(11):770-772.
204. Howes M.D., PhD., R. (2009). Dangers of Antioxidants in Cancer Patients: A Review. PHILICA.COM Article number 153. Published 7th February, 2009.
205. Nima Sharifi. Commentary: Antioxidants for Cancer: New Tricks for an Old Dog? The Oncologist, Vol. 14, No. 3, 213-215, March 2009.
206. Salganik, R. I., Albright, C. D., Rodgers, J., Kim, J., Zeisel, S. H., Sivashinskiy, M. S. & Van Dyke, T. A. (2000) Dietary antioxidant depletion: enhancement of tumor apoptosis and inhibition of brain tumor growth in transgenic mice. Carcinogenesis 21: 909–914.
Generated at: Sun, 20 Jan 2013 08:31:16 -0600 (000002da) — http://www.ispub.com:80/journal/the-internet-journal-of-plastic-surgery/volume-7-number-1/hydrogen-peroxide-a-review-of-a-scientifically-verifiable-omnipresent-ubiquitous-essentiality-of-obligate-aerobic-carbon-based-life-forms.html - See more at: http://www.ispub.com/journal/the-internet-journal-of-plastic-surgery/volume-7-number-1/hydrogen-peroxide-a-review-of-a-scientifically-verifiable-omnipresent-ubiquitous-essentiality-of-obligate-aerobic-carbon-based-life-forms.html#sthash.9hVZUjqH.n4YJ1P4w.dpuf
 
I remember reading a hydrogen peroxide protocol in the book Overcoming Candida by Walter Last. He explained the basics of this therapy and the importance of hydrogen peroxide for the immune system. Here is short version of his protocol:

Hydrogen peroxide 3%. Dose:

10 drops in a glass of water for 1 week.
20 drops in a glass of water for the 2nd week.
1 teaspoon with water for the 3rd week.
1 teaspoon twice a day with water for the 4th week.
1 teaspoon 4 times with water throughout the second month.

This should be done before meals and at bedtime. If you have a 35% solution, dilute 1 part of it with 10 parts of water to make the 3%. You can put it to your tea or drink it with water. 1 teaspoon of 3% peroxide is equivalent to 12 drops of 35% peroxide.

Here is the quote from the book:

You may dilute 35% hydrogen peroxide, or 3% (10 Volume) or 6% (20 Volume) peroxide from a supermarket or chemist. Stabilizers present in some of these products are usually harmless. Best dilute peroxide for daily use to about 3% by adding 1 part of 35% peroxide to 10 parts of water.

Start taking just a few drops in a glass of water. Gradually increase to 1 teaspoon or more four times daily before meals and at bedtime. If you develop an aversion against it, just decrease again to a more comfortable level. Swallow quickly instead of slowly sipping. To disguise the strong aftertaste, add aloe vera gel and fruit flavors, or herb tea, or water flavored with cinnamon.

You may continue this for a month or two and then reduce the intake to only once before breakfast. In addition, use hydrogen peroxide to rinse your mouth, and gargle morning and evening. It helps with thrush and to prevent colds and other infections, and also tooth decay, and is better than toothpaste.

One teaspoon of 3% peroxide is equivalent to about 12 drops of 35% peroxide. Be careful handling 35% hydrogen peroxide, flush any accidental spills on clothes or skin immediately with water or immerse in water. With vaginal thrush douche twice daily with suitably diluted hydrogen peroxide, keep it inside for some time, and follow up by applying some probiotic.

Healthy body cells as well as acidophilus bacteria are not normally harmed by oxygen therapy. In fact acidophilus bacteria produce hydrogen peroxide to destroy Candida and other fungi. You may see www.oxygenhealth.com for more information on oxygen therapies.
 
I've been using food grade 3% hydrogen peroxide as a pre-brush rinse for about 5 years now and the dentist always comments on the health of my gums and teeth. When I tell him what I use, he always says that continuing to use this will cause irritation in my mouth. He never seems to hear me when I say how long I've been using it with no irritation whatsoever. I am under the impression that it is because it is food grade and does not have the impurities that drug store hydrogen peroxxide has. Not sure if that is correct though. Sorry for the one long paragraph. I am on my phone and it won't seem to let me make another one.
 
I've been rinsing with "drugstore" 3% hydrogen peroxide diluted with water after brushing morning and evenings for a while now. I probably swallow a tiny bit when I spit it out, but I'm going to search for food grade.
 
Mrs. Peel said:
I've been rinsing with "drugstore" 3% hydrogen peroxide diluted with water after brushing morning and evenings for a while now. I probably swallow a tiny bit when I spit it out, but I'm going to search for food grade.

The food grade HP usually comes in 12% or 35% so you may need to dilute it to the desired concentration.
 
I found this in the transcripts:

September 09, 2000
[...]

Q: (B) I just didn't want to clutter up the session with personal issues. Is
there something
specific that I should be doing, other than the normal routine things, to promote a
healthier lung
and circulatory system?
A: Diet. Vegetables increase.
Q: (B) That sums it up. Is there any benefit to chelation or peroxide via IV?
A: Chelation is preferable to bypass surgery. Peroxide: topical only, not internal

Is what I bold a particular personal recommendation or a general one? I would think that IV peroxide would be decomposed immediately by catalase enzyme in blood giving oxygen and water with not harmful effects. Many years ago (about 10) I had asthma symptoms and get IV peroxide from a natural physician and it helps me a lot. I don't know of taking it orally could be considerate as "internal" in this context.
 
You may dilute 35% hydrogen peroxide, or 3% (10 Volume) or 6% (20 Volume) peroxide from a supermarket or chemist. Stabilizers present in some of these products are usually harmless.

Is Etidronic acid harmless?
 
When I get sickly feeling, I always put Hydrogen Peroxide in each ear and rinse both sides for 3-5 minutes. Plus if I take some vitamins and get enough sleep, the next day, I usually feel fine. I think it works!
 
Sorry for taking so long ingesting a large posts "backlog" generated by working too much resulting in numbed mind, which just "buzzes" from exhaustion, can't think at the end of day.

If this data about H2O2 and relevant discoveries mentioned are anywhere close to the truth, it is evident that the whole Big Pharma Atrocious Campaign titled "Conning the Masses" could be completely reversed by having the necessary infrastructure - e.g. lab equipment and scientists and producing the goods that really kill cancer and cure any kind of condition caused by modern Civilization if reasonably curable. This info is ASTONISHING!!!!! Too bad that a good team of doctors and scientists would be needed to do effective analysis prolly for years to undo the boons of current food industry embracing the Big Pharma canon.
 
Hyperbaric Oxygen Therapy

The subject of Hyperbaric Oxygen Therapy has been discussed on multiple threads in the health section, but I thought it best to post this great synthesis and update here:

FDA issues deceptive statement about HBOT (Hyperbaric Oxygen Therapy)

http://www.sott.net/article/266253-FDA-issues-deceptive-statement-about-HBOT-Hyperbaric-Oxygen-Therapy

The agency has just issued a warning to consumers. As is so often the case, what they don't tell you is more important than what they do tell you.

The agency's warning begins, "No, hyperbaric oxygen therapy (HBOT) has not been clinically proven to cure or be effective in the treatment of cancer, autism, or diabetes. But do a quick search on the Internet, and you'll see all kinds of claims for these and other diseases for which the device has not been cleared or approved by FDA."

HBOT is approved to treat thirteen conditions: decompression sickness, thermal burns, non-healing wounds, necrotizing soft tissue infections (a.k.a. flesh-eating bacterial disease), acute traumatic ischemias (e.g., crush injury, compartment syndrome), radiation tissue damage, smoke inhalation and carbon monoxide poisoning, air or gas embolism, severe blood loss anemia, refractory osteomyelitis, compromised skin grafts, and clostridial myonecrosis (gangrene).

There are, however, many other conditions that HBOT appears to treat effectively, based on solid or promising research. Licensed physicians and healthcare institutions may legally use an FDA-cleared hyperbaric chamber to treat unapproved or "off-label" diseases and conditions, though it is illegal to promote or advertise such uses. A few doctors are already using HBOT off-label, but not nearly enough of them. Here are some of the off-label applications:

-Traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD), both suffered most often by returning wounded veterans. Tragically, the Department of Defense refuses to use HBOT off-label for veterans, claiming that they don't prescribe off-label medications and treatments for these diagnoses, and saying they can only use HBOT after it has been approved by the FDA for this use.

This isn't even true. The DoD often uses antipsychotic drugs off-label to treat TBI and PTSD. About 20% of veterans diagnosed with PTSD - or nearly 87,000 patients - are prescribed an antipsychotic each year even though it is an off-label use.

In total, including prescriptions outside the military, nearly 280,000 individuals received antipsychotic medications in 2007. Yet over 60% of them had no record of a diagnosis for which these drugs are approved. Antipsychotic drugs were prescribed off-label for PTSD (42% of the patients), minor depression (40%), major depression (23%), and anxiety disorder (20%) - with about 20% having more than one condition.

-Autism. You may recall our story from two years ago where we told you about the successes one mother of three autistic boys had with HBOT. This treatment, like the treatment for brain injury, was pioneered by Dr. Paul G. Harch, president of the International Hyperbaric Medical Association Foundation.

-The American Cancer Society says HBOT can help when used as a mainstream treatment for the prevention and treatment of osteoradionecrosis, a term for delayed bone damage caused by radiation therapy. There is also some evidence suggesting HBOT may be helpful as an extra treatment for soft tissue injury caused by radiation.

-The Undersea and Hyperbaric Medical Society's Committee on Hyperbaric Oxygen Therapy also recommends it for treatment of thermal (heat) burns, abscess in the brain or head, osteomyelitis (chronic bone inflammation) that does not respond to standard treatment, and blockage of the retinal artery (blood vessel in the back of the eyeball).

-Some research indications - where HBOT is performed on a more experimental basis - include acute carbon tetrachloride poisoning, cerebral palsy, cerebrovascular accident (acute-thrombotic or embolic), fracture healing and bone grafting, hydrogen sulfide poisoning, invasive aspergillosis, sickle cell anemia crises, brown recluse spider bites, and acute spinal cord injuries.

-Stroke, Lyme disease, major viral infections, multiple sclerosis, heart disease, sinusitis, head injuries, and many other problems may respond well to HBOT, but it is rarely prescribed for any of these conditions.

Oxygen is necessary for healing. HBOT saturates tissues with ten to thirteen times as much oxygen as can normally be breathed in. Hyperbaric chambers and hyperbaric oxygen therapy have been used clinically since the mid-1800s. HBOT was tested and further developed by the US military after World War I. Today, nearly every hospital owns a hyperbaric oxygen chamber. Most of these sit empty and unused.

With so many conditions that HBOT can treat effectively, why in the world should we keep people sick or in pain when we have the means to ease and even reverse their condition? And why is FDA issuing warnings to consumers to keep them from pursuing such a vital therapy?

The FDA's consumer warning continues that HBOT is not "the kind of universal treatment it has been touted to be on some Internet sites. FDA is concerned that some claims made by treatment centers using HBOT may give consumers a wrong impression that could ultimately endanger their health."

The warning continues, "Patients may incorrectly believe that these devices have been proven safe and effective for uses not cleared by FDA, which may cause them to delay or forgo proven medical therapies." "Proven medical therapies" like dangerous drugs and expensive, invasive surgery, perhaps?

This is part of the problem. The FDA tends to protect therapies that are non-natural and patentable, so that drug companies can afford to spend $1 billion on average for agency approval. Bringing these drugs through the approval process pays the agency's bills, including salaries. Indeed much of the cost of the FDA is born directly by drug companies, which creates a huge conflict of interest.

The other piece of information left out of the FDA's warning is that patents on HBOT tanks ran out long ago, so that bringing the therapy back for additional use approvals is very difficult if not impossible. The FDA is thus telling you not to use it for unapproved uses, but failing to disclose that other uses will likely never be approved, that pleas for government funding of HBOT research will go nowhere, and that the agency itself won't lift a finger to do something about this situation, no matter how much human suffering this policy creates.
 
Laura said:
New Article on the topic:

The Internet Journal of Plastic Surgery ISSN: 1528-8293

Hydrogen Peroxide: A review of a scientifically verifiable omnipresent ubiquitous essentiality of obligate, aerobic, carbon-based life forms

(...)

The US is experiencing epidemics of cancer, diabetes, obesity and fatigue, which may be related to increased ingestion of antioxidant vitamins and dietary supplements, which are now commonly found as supplements or fortifiers of many foods and are aggressively marketed to an ever-growing segment of the population. These agents could be interfering with or modifying our continually operational prooxidant protective system.

Despite two decades of controversy regarding the use of dietary antioxidant supplementation during conventional chemotherapy and radiation therapy, questions remain about their efficacy and safety. However, on the basis of published randomized clinical trials, the use of supplemental antioxidants during chemotherapy and radiation therapy should be discouraged because of the possibility of tumor protection and reduced patient survival. 202

let's hear this again: "reduced patient survival"

and

"In fact, recent findings from randomized controlled trials (RCTs) have repeatedly failed to support the free radical theory and some trial results have even shown harmful effects and increased risk of mortality from antioxidant use. "

and

The US is experiencing epidemics of cancer, diabetes, obesity and fatigue, which may be related to increased ingestion of antioxidant vitamins and dietary supplements, which are now commonly found as supplements or fortifiers of many foods and are aggressively marketed to an ever-growing segment of the population. These agents could be interfering with or modifying our continually operational prooxidant protective system.

i don't think i've ever read such a damning article about the use of antioxidants.
it's absolutely astonishing. this thing is based on over 200 papers and studies ...

is the whole "antioxidants are healthy" and "oxygen free radicals are killing us" really just an outgrowth of ponerized medical science? just like the "cholesterol causes heart disease" scam?

given my health history (and my forum name), i'm certainly partial to believe this to a good degree ...

- my first experience with h2o2 dates now ca. 10 years back, when my joints started to become really painful due to what i later found out must have been the effects of the lyme vaccine, which i assume gave me a new strain of lyme. so i started doing soaking baths in 1-2 cups of 35% h2o2 and the pains in my fingers disappeared literally after one bath.

- i also had a really bad case of dandruff. to the point that bloody pieces (half the size of a finger nail) of my sculp were peeling off. i had to get a special shampoo for that, which was so toxic that i couldn't just buy it over the counter, i had to get a prescription from a doctor every time i needed a new bottle. it was naaasty ... anyways, during my first h2o2 bath i made sure i was soaking the hair and sculp as well (i kept my face out of the water though) and the improvement was dramatic and was getting better and better the more h2o2 baths i took.

- i also used to have really bad stinky feet. for that reason, buying new shoes was a highly embarrassing procedure which required me to buy outside of busy shopping hours and to always look for the most secluded corner in the shop before taking off my shoes. after i started taking the h2o2 baths i ended up wearing the same pair of socks for 2 weeks straight, cause my feet just wouldn't stink. nowadays i spray my feet with 3% h2o2 before i put my socks on to keep that effect.

- i also used to work out on the treadmill in the gym. no matter how much cardio i did, my lungs always felt tight and it was always a very strenuous affair for me. sometimes other people would come up to me and ask me, whether everything was ok (i was 28 yo back then), cause my face would turn blood red and i seemed to be close to a heart attack. after starting the h2o2 baths the breathing got very easy, i had the feeling i was able to run for ever. it was a really astonishing improvement.

- then when i found out i had lyme i started drinking h2o2 - in a highly diluted manner, as suggest by previous posters, and it was helping me a lot with fatigue, digestive problems and brain fog
 
Back
Top Bottom